Podcasts about biodesign

This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: The degradation of community ties across America has created an unprecedented health crisis, impacting millions of lives. Our next guest, Darin Buxbaum, is addressing this epidemic as co-founder and CEO of Wider Circle. Drawing from personal experience and deep healthcare expertise, Darin is pioneering an innovative approach that connects health plan members with trusted neighbors to create lasting, supportive communities. Previously founding successful healthcare ventures and recognized among the top 40 Innovators Under 40, Darin brings unique insights to community-driven health improvement. Join us to discover how Wider Circle's peer support model is revolutionizing healthcare delivery, reducing costs, improving outcomes, and most importantly, giving people a renewed sense of purpose and belonging. Let's go!Episode Highlights:Inspired by his grandmother's isolation after losing her spouse, Darin founded Wider Circle to combat loneliness through community connectionThe company matches engaged and less engaged health plan members in peer groups to build trust and encourage preventive careResults show $115 monthly cost savings per member, fewer hospitalizations, and 50% lower member attrition ratesProgram serves both Medicare and Medicaid members across generations, from maternity groups to senior support servicesCommunity "ambassadors" drive engagement by supporting peers and checking on absent members, especially in rural areasAbout our Guest: Darin Buxbaum is the co-founder and CEO of Wider Circle, a company focused on building communities to improve health and quality of life through trusted connections. Previously, he was co-founder and VP of Product at Oration, an insurance tech company, enabling self-insured employers' major reductions in prescription drug spending. He also founded HourGlass Technologies where he served as president and CEO for over five years, and also drove the development of a new medical-device technology. Darin was recognized as one of the top 40 Innovators Under 40 in the Medical Device and Diagnostic Industry, and currently sits on the Forbes Business Council. Wider Circle was also named to the Inc. 5000 Fastest-Growing Private Companies in America for 2024. Darin graduated Summa Cum Laude from Duke University and earned an MBA from Stanford University. Darin remains active with Stanford as a contributor and mentor to the BioDesign course and textbook.Links Supporting This Episode:Wider Circle Website: CLICK HEREDarin Buxbaum LinkedIn page: CLICK HEREWider Circle LinkedIn page: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK...

Anurag Mairal, PhD joins us on Making AI Work for You about the role of technology in shaping and advancing healthcare worldwide.   Dr. Mairal talks to us about the importance of keeping all stakeholders in mind, and focusing on technology-enabled solutions that are patient-centered. He also talks about the role of policy as a lever to change.    Anurag Mairal is the Director of Global Outreach Programs for the Stanford Mussallem Center for Biodesign, and is an Adjunct Professor, Stanford University School of Medicine.   Topical timecodes:  1:28 - Merging areas of expertise for the greatest social impact 4:07 - Approach to healthcare solutions  - from sick care to healthcare to health 7:43 - how to use AI and tech to fill the gaps, helps patients, and is financially sustainable 12:05 - Digital native companies and traditional healthcare 15:36 - The role of policy in healthcare change  19:45 - Advice to others, 3 areas that help make an impact    Connect with Anurag Mairal: https://www.linkedin.com/in/mairal/  Learn more about Stanford Biodesign: https://www.linkedin.com/company/stanford-biodesign/posts/?feedView=all

In this milestone episode of Life of Flow, vascular surgeons Miguel and Lucas sit down with Dr. David Hindin — surgeon, innovator, and assistant director of Stanford's Biodesign program. With over 58,000 YouTube subscribers, Dr. Hindin is at the forefront of bridging creativity and medicine. He reveals the secret framework that's transforming healthcare innovation.If you've ever had a breakthrough idea but felt stuck navigating the red tape of the healthcare system, this episode is your guide to taking action. From identifying the right problems to scaling life-changing solutions, Dr. Hindin walks us through the proven steps to turn your creative sparks into real-world impact.00:00 – Introduction: Why innovation in healthcare often stalls.02:15 – Meet Dr. David Hindin: Surgeon, innovator, and creative thought leader.05:42 – The Stanford Biodesign method: From unmet needs to scalable solutions.13:25 – Breaking down barriers: How doctors can overcome system inertia.18:47 – The power of clinical immersion: Solving real problems where they happen.22:10 – Case study: How observation turned into a groundbreaking hearing device.27:36 – Key steps to successful innovation: Execution over ideas.34:12 – Overcoming fear: Reclaiming your creative side as a physician.

This week, we revisit our interview with Nick Damiano. Nick is a serial entrepreneur focused on solving unmet needs to improve patient care. He is currently CEO & Founder of Andromeda Surgical, which is developing autonomous robots for safer, better, more efficient surgery. Before that, he was CEO & Co-Founder of Zenflow, where he co-invented a novel implant for BPH (enlarged prostate) and led the product from inception through multiple clinical trials to commercial readiness, raising over $60M in funding. He was also CTO & co-founder at Nurep, later re-branded as Avail MedSystems. He was the key architect of the company's remote surgical support product for operating rooms that is now used in hundreds of medical facilities. Nick earned his M.S. and B.S. with Distinction in Management Science & Engineering from Stanford University and was an Innovation Fellow at Stanford Byers Center for Biodesign. He was the first medtech founder to be funded by Y Combinator twice and actively advises startups through StartX, UCSF Rosenman Institute, and Nucleate Bio. He also dabbles on the investor side as a Venture Partner at Pioneer Fund.

Transcript: rmad.ac/AIAe0645Rebecca Rosenberg is an engineer, entrepreneur, speaker, and a person with albinism. Growing up she struggled to find assistive technologies that supported her needs as a person with moderate vision impairment. In 2019, Rebecca founded ReBokeh to develop assistive technologies specifically for the albinism and moderate low vision communities.After receiving her bachelor's degree in biomedical engineering from Bucknell University, Rebecca began coursework at the Johns Hopkins Center for Bioengineering Innovation and Design (CBID) where she received her Master's degree of the same title. Following her masters, she was awarded an Abell Foundation Fellowship to assist in developing and teaching the Biodesign curriculum to first year masters students. She also served as the project lead for VectorCam, a global health initiative aimed at using artificial intelligence to combat malaria in sub-Saharan Africa.Rebecca now devotes her full time to ReBokeh: having deployed the technology to a growing base of users in over 70 countries worldwide and speaking to various groups on the unique challenges of the moderate low vision community.Connect with Rebecca:Website: Home | ReBokehReBokeh Vision Technologies, Inc. | LinkedInReBokeh • Vision Assist Technology

Discover the fascinating world of digital health innovation with a leading expert in vascular surgery and digital health innovation, Dr. Oliver Aalami. In this insightful People of AI episode, Dr. Aalami shares his path to medicine, his passion for integrating technology in patient care, and his role as director of Stanford's Biodesign for Digital Health program. Explore the groundbreaking projects and initiatives shaping the future of healthcare. Resources: Stanford profile → https://goo.gle/49nPZF7 Biodesign for Digital Health → https://goo.gle/4fYf0ZV GitHub Stanford Spezi → https://goo.gle/4g9TZLS 21st Century Cures Act → https://goo.gle/41BwsPV Chapters: 0:00 - Introduction 0:33 - Dr. Alami's journey 6:08 - Biodesign for Digital health intro 24:29 - GitHub Spezi 26:44 - Where does AI come into digital health? 32:50 - Use cases and examples 41:27 - What does it mean to be a person of AI? 

Are you curious about the biotechnology startup world? Learn how our guest transitioned from trauma surgeon to entrepreneur in this episode of the BackTable Podcast. Dr. Chris Kinsella, CEO of Watershed Therapeutics and our host Dr. Bryan Hartley discuss the importance of using entrepreneurship to solve clinical needs. Watershed Therapeutics has created a novel bladder drug delivery platform to help women with recurrent urinary tract infections. --- SYNPOSIS The doctors systematically cover the process of identifying market needs, inventing solutions, bringing a product to the market, and managing risk. They also share examples of successful startup ventures and underscore the importance of perseverance, innovative thinking, and strategic market focus in forging a path to success. --- TIMESTAMPS 00:00 - Introduction 04:30 - The Birth of a Surgical Trainer 07:04 - Challenges and Innovations in Trauma Surgery 22:06 - Evaluating and Killing Ideas 28:27 - Challenging Assumptions 29:53 - Meeting a Co-Founder 33:07 - Developing the Solution 37:29 - Raising Funds 40:28 - Navigating Regulatory Challenges and Market Expansion --- RESOURCES Watershed Therapeutics: https://www.watershedtx.com/ Stanford Biodesign Innovation Fellowship: https://biodesign.stanford.edu/programs/fellowships/innovation-fellowships.html

Are you curious about the biotechnology startup world? Learn how our guest transitioned from trauma surgeon to entrepreneur in this episode of the BackTable Podcast. Dr. Chris Kinsella, CEO of Watershed Therapeutics and our host Dr. Bryan Hartley discuss the importance of using entrepreneurship to solve clinical needs. Watershed Therapeutics has created a novel bladder drug delivery platform to help women with recurrent urinary tract infections. --- SYNPOSIS The doctors systematically cover the process of identifying market needs, inventing solutions, bringing a product to the market, and managing risk. They also share examples of successful startup ventures and underscore the importance of perseverance, innovative thinking, and strategic market focus in forging a path to success. --- TIMESTAMPS 00:00 - Introduction 04:30 - The Birth of a Surgical Trainer 07:04 - Challenges and Innovations in Trauma Surgery 22:06 - Evaluating and Killing Ideas 28:27 - Challenging Assumptions 29:53 - Meeting a Co-Founder 33:07 - Developing the Solution 37:29 - Raising Funds 40:28 - Navigating Regulatory Challenges and Market Expansion --- RESOURCES Watershed Therapeutics: https://www.watershedtx.com/ Stanford Biodesign Innovation Fellowship: https://biodesign.stanford.edu/programs/fellowships/innovation-fellowships.html

Curious about how you can revolutionize healthcare innovation through artificial intelligence? What happens when you add a touch of New Orleans flair to a BioDesign program? In this episode, JoJo Platt, President of Platt & Associates, Inc., joins host James Zanewicz, JD, LLM, RTTP, to discuss the exciting launch of the Tulane AI & Healthcare Design Lab, taking place November 14-17, 2024. JoJo brings a wealth of experience from her successful Cleveland NeuroDesign Workshop to share how this upcoming program will train the next generation of innovators in AI and healthcare. In this episode, you'll discover: The objectives of the AI & Healthcare Design Lab and what makes it a unique twist on traditional BioDesign programs. A glimpse into the weekend's agenda and the real-world healthcare applications that participants will be exploring. How to apply to the AI & Healthcare Design Lab and what they're looking for in applicants. Tune in to learn about this exciting event and how you can be part of it! Links: Check out the Tulane AI & Healthcare Design Lab and APPLY by October 1st, 2024. Connect with JoJo Platt. Check out Episode 35: Cleveland NeuroDesign. Connect with James Zanewicz, JD, LLM, RTTP and learn about Tulane Medicine Business Development and the School of Medicine. Check out program sponsors: Envisagenics, New Orleans BioInnovation Center, Cleveland NeuroDesign, The Alliance for Artificial Intelligence in Healthcare, Women in AI, and Platt & Associates, Inc. Check out BIO on the BAYOU and make plans to attend October 29 & 30, 2024. Learn more about BIO from the BAYOU - the podcast. Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.

Darin Buxbaum, MBA, is the co-founder and CEO of Wider Circle, a technology-enabled health services company that empowers members of the same community to live happier, healthier lives. He shares the outcomes of Wider Circle's peer support groups and provides insights for aging individuals and their families. About Darin Darin Buxbaum's extensive healthcare experience includes proven success both as an entrepreneur and as a leader in the enterprise space.  He's co-founded digital health, insurance tech, healthcare services and medical device companies and led large initiatives at a Fortune 500 company.  Currently, he's the co-founder and CEO of Wider Circle, a technology-enabled health services company. Previously he was co-founder and VP of Product at Oration, an insurance tech company enabling self insured employers and their employees to dramatically reduce their prescription drug spend.  In the medtech space, he founded HourGlass Technologies, a healthcare technology start-up, and served as president and CEO for five-plus years. There, he drove the development of new medical-device technology from concept to clinical trial, earning recognition as a top 40 Innovators Under 40 in the medtech industry from Medical Device and Diagnostic Industry. Darin's enterprise experience includes leading the largest digital health initiative at Medtronic where he was awarded the Star of Excellence, the company's highest honor. Darin graduated Summa Cum Laude from Duke University and earned an MBA from Stanford University, graduating as an Arjay Miller Scholar.  Darin remains active with Stanford as a contributor and mentor to the BioDesign course and textbook. Key Takeaways Personal connections are key to health and happiness. An African proverb says: if you want to go fast, go alone. If you want to go far, go together. Wider Circle's peer support groups for vulnerable populations are subsidized by health plans and physician networks because the individuals who would benefit most from neighborhood-based health initiatives are often the least able to afford them. The outcomes from Wider Circle's peer support groups include reducing loneliness by over 65% against the match control population and increasing the number of healthy days by 43%. Health plans see a cost reduction of $100 per month and reduced hospitalizations by 15%.

I have two guests with me on this episode, which is really exciting because one guest is going to share the science behind a specific type of therapy, and the other guest is someone who has been using this therapy, and she is going to share all of the benefits that she's noticed from it! On today's episode, John educates us on UVB light therapy for multiple sclerosis and Kathy shares her experience using it. Kathy's bio: Kathy Reagan Young is a prominent patient advocate and the founder of FUMSnow.com. She has become a leading voice in the patient advocacy space, driven by her personal experience with Multiple Sclerosis.Kathy's journey as a patient advocate began when she was diagnosed with Multiple Sclerosis in 2008. She quickly realized the impact that chronic illness can have on a person's life and became determined to make a difference. In 2010, she founded FUMSnow.com, a website dedicated to providing resources and support for people with Multiple Sclerosis. In 2015, she launched The FUMS Podcast Show - a companion to her website where she interviews MS experts and inspirational MS patients to bring information, inspiration, and motivation for living your best life with MS. John's bio: I have been fortunate to have spent my career on early-stage medical device start-ups. I am a graduate of Stanford University with a master's in electrical engineering and a bachelor's in physics from UC-Santa Cruz. At Stanford, I was fortunate to be in the penultimate class of the BioDesign program that brings together clinicians and engineers to identify clinical needs and innovate to improve patient lives and ease the burden on clinicians. Resources mentioned in this episode: Webinar of the “Silent Symptoms” Trial — Including Our Journey from COVID to MS - https://www.cytokind.net/release/ms-uvbtrial/ Silent Symptoms Trial Design - https://www.cytokind.net/trials/athomephototherapytrials/ Website: www.cytokind.net & https://daavlin.com/ Kathy's weekly newsletter: https://fumsnow.com/get-the-scoopKathy's website: https://fumsnow.com/ Additional Resources: https://www.doctorgretchenhawley.com/insider Reach out to Me: hello@doctorgretchenhawley.com Website: www.MSingLink.com Social: ★ Facebook: https://www.facebook.com/groups/mswellness ★ Instagram: https://www.instagram.com/doctor.gretchen ★ YouTube: https://www.youtube.com/c/doctorgretchenhawley?sub_confirmation=1 → Game Changers Course: https://www.doctorgretchenhawley.com/GameChangersCourse → Total Core Program: https://www.doctorgretchenhawley.com/TotalCoreProgram → The MSing Link: https://www.doctorgretchenhawley.com/TheMSingLink

We leven in de begraafplaats van de natuur. Onze gebouwen, voertuigen, wegen en bruggen zijn gemaakt van dode materialen. Wat als die zouden leven? Dat is het levenswerk van biodesigner Bob Hendrikx. Hij haalde het wereldnieuws met de door hem uitgevonden doodskist van levende schimmeldraden, mycelium. Als het aan hem ligt het bouwmateriaal van de toekomst. Wonen we straks in een schimmel?Gast: Bob Hendrickx Presentatie: Jessica van der Schalk & Wouter van NoortProductie: Henk Ruigrok van der WervenMontage: Yeppe van KesterenVind je deze onderwerpen interessant? Meld je dan aan voor: de Future Affairs NRC NieuwsbriefZie het privacybeleid op https://art19.com/privacy en de privacyverklaring van Californië op https://art19.com/privacy#do-not-sell-my-info.

Bioconjugation of antibodies to drugs via chemical linkers is how antibody drug conjugates (ADCs) are made. We're joined by Matt Giese, Senior Scientist at Vector Laboratories, who talks us through the complex chemistry options and biodesign considerations that have to be considered and balanced when making a successful ADC.How does one build the skillset to work in biodesign of ADCs you might ask? Well, Matt's career path might not provide a clearcut roadmap like you might hope. That's because Matt started his career as an auto mechanic, moved into art, went back to auto mechanics, worked as baggage handler and as a construction worker, all before ever finding chemistry. If you think that's a convoluted path, just wait to hear about his academic and professional work journeys.  You'll revel in following this journey, and in the lessons and diverse skills learned along the way. Join us to hear it yourself, from who might just be the most interesting man in chemistry!Related episodes:Season 5, Ep.7: The life-altering impact of one chemist's sabbaticalSeason 2, Ep.1: Chemistry: a modern American dreamSeason 3, Ep.5: On the COVID pill and other process chemistry tales Bonus content!Access bonus content curated by this episode's guest by visiting www.thermofisher.com/chemistry-podcast for links to recent publications, podcasts, books, videos and more.View the video of this episode on www.thermofisher.com/chemistry-podcast. A free thank you gift for our listeners! Request your free Bringing Chemistry to Life t-shirt on our episode website.Use Podcast Code: LabRatsRul3 in July or OchemRcks in August. We read every email so please share your questions and feedback with us! Email helloBCTL@thermofisher.com

Meet Holly Rockweiler, CEO of Madorra. This episode explores the transformative journey of Madorra from a Stanford Biodesign fellowship project to a pioneering force in women's health aiming to revolutionize the treatment of vaginal atrophy and dryness without hormones. Holly's story is not just about groundbreaking medical devices, but also about the passion and determination that drive the quest for better healthcare solutions. Through engaging storytelling, this episode unveils the challenges and triumphs of bringing novel technologies to market, the power of female leadership in STEM, and the broader impact of MedTech on improving lives.  Guest links: www.madorra.com | https://www.linkedin.com/company/madorra-inc-/ | https://www.facebook.com/MadorraMedical | https://twitter.com/MadorraMedical Charity supported: Equal Justice Initiative Interested in being a guest on the show or have feedback to share? Email us at podcast@velentium.com.  PRODUCTION CREDITS Host: Lindsey Dinneen Editing: Marketing Wise Producer: Velentium   EPISODE TRANSCRIPT Episode 033 - Holly Rockweiler [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. [00:00:51] Hello, and welcome back to another episode of The Leading Difference podcast. I'm your host Lindsey, and I'm so excited to introduce you to my guest today, Holly Rockweiler. Holly is co-founder and CEO of Madorra, a woman's health company dedicated to changing the treatment paradigm for vaginal atrophy and dryness. She co-founded Madorra as a spin out of the Stanford Biodesign fellowship, where she implemented ethnographic research to identify unmet clinical needs and define user market and product requirements for solutions and women's health, urology, and infectious disease. Prior to Biodesign, she worked as a Senior Research Scientist at Boston Scientific, where she developed therapies to enable more efficient care for patients living with heart failure. Her preclinical and clinical research has led to more than 20 pending and issued patents. Holly holds an MS and a BS in Biomedical Engineering from Washington University in St. Louis. Welcome, Holly. It's so wonderful to have you here today. Thanks so much for joining us. [00:01:49] Holly Rockweiler: Thanks for having me. [00:01:51] Lindsey Dinneen: Yeah, absolutely. Well, I was wondering if you wouldn't mind starting off by telling us a little bit about yourself and your background and maybe what led you to the medtech industry. [00:02:02] Holly Rockweiler: Sure. So let's see. So my background is in biomedical engineering. I majored in biomedical engineering. Maybe I can say why, like I, I knew that I wanted to be an engineer. I felt like, well, first of all, as a woman in math and science growing up, when I did every teacher told me to be an engineer, but I didn't really know what that meant until I got to college, but I liked it. Pursued engineering and I started undecided, but very quickly found that I was, most just excited about the problems in the biomedical engineering field. I remember one of my classes was like "calculate the torque of a drill on a tooth," I was like, "Wow, that's amazing. I think I found it." [00:02:41] So majored in biomedical engineering, got my master's and bachelor's at Wash U in St. Louis, and then I went to work for Boston Scientific. And so they are a medical device company. And so that's obviously how I got into it, but I did seek that out. When I was thinking about what did I want to do, I thought about... chemistry was never an area I felt very strongly about. I liked stuff I could hold in my hands and really conceptualize. And so I think that's what led me more in the device road and then had a incredible opportunity to work at Boston Scientific. [00:03:15] And so I worked there for several years in their implantable cardiac division. So that's pacemakers and ICDs, working in the research department. So that was also really cool because we were on the front end helping to define the next generation products and was able to also work very cross functionally. So just because research conceived of an idea didn't mean it was going to be in the product development had to help it go forward, and obviously we were keyed in very closely with the marketing team to understand. What were the needs that we were solving. [00:03:45] So it was an incredible introduction to our industry. And then I decided that I wanted to try a smaller company. There was just some broader themes of working in a large company that didn't totally jive for me. And so I was like, "Well, I don't know the first thing about startups." So I had heard about the Stanford Biodesign program, which is where I went next. And the company that I started, Madorra, is a spin out of that program. [00:04:14] Lindsey Dinneen: Wow. Okay, so your path is really cool, and I love that you are an engineer, and I love your passion behind it too, just hearing you talk about that one random problem and your excitement about it. I adore that. I do. Because that is not my leaning. So whenever I hear somebody just get really excited about that kind of thing, I'm like, "Yes, tell me more." [00:04:40] Holly Rockweiler: Well, then you're in the right field too, I would say. [00:04:42] Lindsey Dinneen: Indeed. Indeed. Indeed. So, yeah. I'm just curious. Okay. So, so going back just a little bit, you started off at Boston Scientific and kind of developed this appreciation for the medical device space and innovation. And then with Stanford Biodesign, can you tell me a little bit about being a part of that and then how you were able to spin off into your own company? I mean, that's not, that's like a one sentence thing that you put in there, but I know that it took a lot of work, and I'd just love to hear about that process, and your experience. [00:05:17] Holly Rockweiler: So, absolutely. So, the Stanford Biodesign program has many different facets. I was part of the fellowship, but they also have classes they teach and books and online resources. And then other universities have kind of sister programs around the world, frankly. So I was very interested in joining the program, like I said, to kind of-- what I was telling myself was like a way to dip my toe in the water of what a smaller company would be like. Now that's not at all what Stanford pitches the biodesign program as. Really what it is a an academic training program for an innovation process. And that's what they teach you. Now there are a lot of companies that end up spinning out of it. [00:05:56] And so I thought, "Well, maybe, like I said, this is a way to dip my toe in the water, but also if I decided to come back to a larger company setting, this skill set still would be highly useful given what I want to do in my career. So that's what I set out to do. And so the program I love, I think is fantastic. It's as described initially, it's this innovation process and they teach you that in a very hands on way. So first you start with really understanding and building a list of unmet needs, and so that starts by looking for problems in Stanford Hospital. You kind of have this unfettered access as an engineer. It was the 1st time I had that, you know, observe and ask questions and talk to physicians and patients and other health care professionals and then. you end up with, obviously, a long list of problems that you can find, just like any, anywhere in the world, right? This could happen. But also this, in healthcare, it happens. [00:06:55] And then you translate those problems into what the program calls need statements, to really-- there's a lot packed into that, but once you have those, then you spend the bulk of the program actually learning how to filter that long list of problems down into a couple key top unmet needs that you're working on. And so again, this is their goal is academic. They want to teach them their product is the people. They want to teach people this process and have them go out and share this process and use it to be successful in whatever, you know, vein they end up going down. [00:07:32] And so I was like, I was just having a conversation with my husband this weekend. I was like, we were talking about something interpersonal and I said, "Well, the unmet need here really is..." So it certainly has, you know, I've drank the Kool Aid completely and love to share it. So, but anyways, so, but what happens because you're working hands on these projects you very often, which was the case for myself and my co founders, by the end of the year, you may have something that you're pretty passionate about. [00:08:00] And so what has now become my about me description is working in women's health. I had no idea how passionate I would be about. I feel like I kind of backed my way into it, but now kind of reviewing that history, it's like, "Oh, maybe I was always kind of destined for this given my interest in, in, you know, activism." So kind of combining all of this together is what led us here. So, spinning it out was a consequence of having a lot of hard work with my team throughout the year. And we had other projects too, but this became the one that kind of survived every stage gate. And we ended up spinning out. into the company, Madorra. [00:08:42] Lindsey Dinneen: Wonderful. Well, thank you for sharing a little bit about that. And also, I love the crossover into real life, not that's not real life, but I do your daily life as well. Oh my gosh. That's great. I'm going to start doing that. Okay, so can we talk now a little bit about your company and the product that you've developed and where you're kind of looking to take it in the future? [00:09:05] Holly Rockweiler: Certainly. So, again, being born out of Stanford, we started with an unmet need around creating a treatment for vaginal dryness and atrophy for postmenopausal women that didn't rely on hormones. So this is a problem that I had never heard of before we literally met patients with this problem and talk to providers about this problem. And as we started researching, "Wow, up to 75 percent of all postmenopausal women are dealing with some, you know, degree of this. How have we not heard of this before?" That is a striking number of people. [00:09:39] And so as we continued to do our research, very quickly learned the gold standard treatment here is hormone therapy, but even though this market is huge, only 7 percent of the market is using hormones today. And so that... there's a lot of reasons why, but that's really what motivated us to say, "Wow. There needs to be another option." Because if you don't want hormones right now, the only other FDA cleared product or category for treating this are over the counter lubricants and moisturizers. And those are like, both of the products that exist today are really, those categories are really great, but they're not enough. [00:10:16] And again, with 43 million women in the United States with this problem, like we need more than just those two categories. And it really felt like no one had really looked at this. I mean, hormones, again, are a good solution for the patients who want to or can use them. But for patients who can't, for example, breast cancer survivors, they're stuck with, you know, just kind of subsisting off these over the counter products that really are not enough when your case is more moderate or severe. [00:10:43] And so we said, "Well, let's look at this and see if there's a better way or, you know, something we could combine," and ended up developing the idea for what is now the main product that we're developing at Madorra, which is a home use device that uses ultrasound to really rekindle the body's natural lubricating process. And so our whole goal has been to be very supportive of the other products in this category. We think hormones should be used more often than they are, frankly, but that women shouldn't have to make a compromise. If they don't want to use hormones, then they should have other options, and that's where we come in. [00:11:21] So our product, we will, it's not on the market yet. We're working towards that, but when it's out there, what we envision is a prescription happens from the gynecologist, and then the patient uses the product at home on a regular basis to, like I said, kind of revitalize that natural process. And what patients have told us they like about this is that It is restarting their own natural lubrication rather than some exogenous hormone or chemical. And there's less of a kind of a goop ick factor, you know, than having to use these over the counter things, which again, they like say that not to say that those don't have their place because they absolutely do, but it's not enough. [00:12:01] And so, we're pre FDA clearance, but we have a breakthrough designation from FDA. So that's feather in our cap and will help us get through the agency more expeditiously. And we have done several clinical trials and look forward. We've published one of those trials in our first manuscript, and we look forward to putting more of our data out there to help really lay the foundation to say, "Yeah, ultrasound is an appropriate approach to treating this and has virtually no side effects." So this should be a great option to be available to as many people as possible. [00:12:36] Lindsey Dinneen: Oh, that is incredible. Oh my goodness. Well, yeah, first of all, again, you know, it boggles my mind and it probably shouldn't anymore, but it continues to when you tell me statistics like this, that 75 percent of women who've are in this situation or have this concern or whatnot. And you're just think, you're addressing it in a way that's so innovative. And yet that hasn't really been addressed yet and it happens again and again with healthcare for women. And I'm wondering, you know, you mentioned earlier being very passionate about this. So I'm wondering if you can speak a little bit to fem tech and women's health and how you're involved in helping to push the conversation forward 'cause I know that can be a little challenging at times. [00:13:23] Holly Rockweiler: Absolutely. Yeah. And well, it's super fascinating too, because we spun out of Stanford in 2014. So we're coming up on 10 years here and the conversation is so different today than it was just, well, just 10 years. I mean, it was a decade, but it feels like yesterday. Like a lot has changed. When we first were starting Femtech wasn't a hashtag, like that was not a conversation. And people would say like, "Ooh, that's a niche." Yeah. And that doesn't happen anymore, which is really great. So while that's, that's certainly progress, so we should acknowledge that and be proud of everyone who's worked towards creating that progress. So I think what's been interesting, though, it's like the pace of progress, maybe? [00:14:09] So it's very exciting to know that there are, for instance, obviously I spend a lot of my time fundraising, there are women's health focused venture groups now. They, that's fantastic. That we just need bigger and bigger funds to be focused on that. We just need more and more We need more of everything, right? I mean, one of many things I've been very surprised to learn is how little training physicians get on menopause specifically. And so that has to change. And so there's just like a lot. [00:14:40] And so to the point of activism, like there's a lot to say, and so I think, it's... being raised by parents who are feminists, that helps, I think, me just start by saying, "Well, no, this shouldn't be . We can do better, and we will do better." So that's helpful, and I think that's also what really keeps me going-- obviously, every job is hard, and in our startup world, this is certainly a lot emotional rollercoaster. And so when I think about when I have harder days, it's like, "Wow." We've had patients tell us, for example, "I can't believe you're even paying attention to this. I can't believe you're listening to what I have to say." And so one, that's disturbing that's, as little as it's needed to make someone feel better. Secondly, it's "Wow, we can have such an impact by just being out there." So like the fact that we exists, I always think is helpful and that we do things like this and have open conversations about vaginal health for an aging population. [00:15:39] I will also say that, a year ago at the Super Bowl last year, there was an ad for a hot flash drug. And so that's like, you know, the world stage, menopause is being discussed. That was not happening 10 years ago. There is real progress being made. The last thing I want to say is that one thing I, I have also really appreciate about working in women's health and how supportive everyone is of everyone else. Every, anytime, even like our closest competitor, when I met their CEO, she was wonderful to me and, you know, shook my hand and said, "How can I help you?" And it's like, "Where else does that happen?" That's incredible. I think 'cause we all see there's a lot of work to be done. We can't do it alone. We want to support each other. [00:16:19] Lindsey Dinneen: Oh, I love that. Yeah, that is something that I have really admired and appreciated about the medtech industry. I think because people are curious, and their mindset is very innovation problem solving, "how can I help?" It seems like even with competitors. Yes, we're maybe vying for similar people to sell to. However, there's this idea of camaraderie, which I don't find in a lot of industries. So yeah, to your point, I think it's really helpful to have those allies in the space because that's, it's a little different. [00:16:53] Holly Rockweiler: Totally. [00:16:54] Lindsey Dinneen: Yeah. So yeah. And I, I love what you were saying about these conversations are happening more and they're becoming more mainstream and less embarrassing or taboo, which sounds hilarious because it's 50 percent of the population or whatever. But anyway, the point being, it is exciting to see this continue to move forward. And I'm wondering, even as a company, obviously your next big hurdle is getting that FDA approval, going to market and whatnot. But as you continue down the road, what other kinds of problems are you looking to solve? Or are you not even there yet? This is just like, "Let's start here. We'll get into that later." [00:17:38] Holly Rockweiler: Yeah. No, it's a great question. I think like what kind of harkening back to the just the prior question about the community of women's health. It's like you can't go a day without finding five other problems that you want to solve. So absolutely. I think that yeah, I mean, like with Madorra, we are very focused obviously on this technology and developing it, but we certainly have a roadmap of where this technology could go and other ideas of where to take it. And then what I find fascinating is that there is no menopause "brand." Like no one owns menopause, which I, if I worked at Procter and Gamble or Kimberly Clark, I would be like, hopefully 15 years ago, I would have said, "Guys, let's do it." So it's very surprising to me. So I think there's a lot of opportunities. [00:18:23] So would Madorra be that brand? I would love that. We would need a lot of other products that come together with us. So what I really see is a roll up in the future of multiple women's health products together. So I think that's exciting. In terms of, also a little bit maybe more broadly speaking, and this is no surprise to you, I'm sure, or your listeners, that reimbursement is an area that needs massive... I don't know, I was gonna say like overhauling, but that sounds pretty drastic. [00:18:53] It just needs to be clearer and cleaner and simpler. In terms of a process. I'm not saying that we should be handing out reimbursement left and right, but any investor conversation I have is, we go there immediately. And it's like, "Okay, what's the path? Well, why do you think that's going to happen?" And when, you know, X, Y, Z, other company had this happen and I can, we have a good strategy. I think I have a good pitch, but, oh, just... it just is an area that is really murky, and given that's a really critical piece in any business is how are you going to get paid? That's an area that I think there's a lot of good work being done. It just moves at a pace that is painfully slow. I don't have anything insightful to say about it except that, thank you to the people who are working on it, and I support you. I think the TCEP program is a step in the right direction, but even that has been very slow, and not without its own issues, so. [00:19:53] Lindsey Dinneen: Yeah. Still work to be done, but thankful for the work that is being done. [00:19:58] Holly Rockweiler: Well said. Yes. [00:20:00] Lindsey Dinneen: So, yeah, so, okay. So obviously, listening to you speak about your background and about the industry, it's really clear how passionate you are about this. And I, I wonder if there are any moments or series of moments that stand out to you as kind of confirming that, "Yes, I am in the right place at the right time. I'm here for a reason." [00:20:23] Holly Rockweiler: Oh, good question. Yeah. I'm trying to think like, there are plenty. There's plenty of times in the moment where it's like, "Of course, yes." And then there's like quickly like, "Oh, what's the next fire I'm trying to put out?" So it's hard to really think. I wish I had a super answer right away. I'm thinking, I guess I always come back to the patient and so like hearing-- so we've done some clinical trials in Australia and various team members of ours have gone over and been able to support the trials and be a part of them. And just hearing the stories that they bring back, it's just like, "Yes, we have to keep doing this." [00:21:01] One of our employees was there and came back with a couple stories of one of them was just like after the study visit, the patient was speaking to her and was saying, "It's a conspiracy of silence. This is a huge problem. So many of us are suffering. We're so glad you're here." And then it's other things like we did, for instance, a human factors study that was really helpful to us. And we learned a lot from, and in that study, it was like patients came in to do mock use of the device so we could improve our training materials and also, you know, all parts of the user experience. And it was amazing to me. [00:21:38] So patients, you know, participants, I should say, got zero benefit theoretically about being in that study. It was all for us to learn how to do this better. I mean, we did compensate them, but marginally, right? And so many people wanted to be in that study. And even if it was the early on patient who had-- I'm going to make it up. I had like, "Oh, the user manual didn't make sense to them" or something. They were still like, "I'm so glad to be here to help you because this product needs to be out there." And so it's like, " This is incredible. Yes!" And that part is really rewarding to me. [00:22:09] For me, it's the patients and their feedback and just their enthusiasm. And then, I was gonna say also for the healthcare providers too, we have a lot of wonderful physicians that we work with and their support has been helpful. Like for instance, as I mentioned, we put a paper out there and one of our clinical advisors was highlight, or I think a couple of them highlighted to us that like, "We need to do a second paper on a specific subset of that data because it's super valuable and hasn't been out there before," which may be the clinicians do that for everything they do 'cause they, they know the scene and they know what needs to be published, but it just felt like we have a lot of people who really are rowing in the same direction and really want to make an impact like we do. [00:22:49] Lindsey Dinneen: Oh, wow. Yeah, that's incredible. Thank you for sharing those stories. I think, you know, as you alluded to earlier, because your role has so many components, because that's the space you're in and you've got so much going on, I think it's really compelling to have something to hold onto when it gets hard and go, "You know what? I remember that patient who was so thankful just to have the opportunity to be a part of it and just wait until this gets into the hands of so many more." [00:23:15] Holly Rockweiler: Totally. [00:23:17] Lindsey Dinneen: Yeah. Yeah. Yeah. And so for you, you know, you obviously have a very strong background in engineering and innovation. How was it for you going from that to also now being an entrepreneur, and having a business, and having to also learn all of those skills as well. How was that transition? [00:23:42] Holly Rockweiler: Fun. I think that-- there's a lot of personal growth, and I've learned a lot about myself and what where I find passion. So I think there's definitely a lot of hard parts too, but what, well, one thing is that I think there's also a heavy dose of naivete that was important. I didn't know what I didn't know. And so here I am 10 years later I think, you know, in the beginning too, I was not... what do I say? I wasn't convinced, yeah, I wasn't convinced that I could be a CEO, that I should be or could be. And so I think that was, and is maybe still a definitely a continuous journey to it. So why is, why did I think that? What does that mean to me? And where am I now? That's been certainly a learning process. [00:24:31] But that's also like why I said fun, because I, I get to do such a variety of, like, I get to have this opportunity to speak to you on this podcast. I get to work with our clinical advisors on a paper. And I also get to apply for grants. And there's a lot of hard things that come with all those things, but I feel like it's been a really, I don't know, just an incredible opportunity to have a job that It requires so many different things. It also requires me to do financial modeling, which I'm terrible-- well, was terrible at-- have learned and much better at, but also don't really love doing. [00:25:04] So it teaches you what, what you might look for in a future chapter of your life as well. But I'm someone who really thrives on, I have a very curious mind. So trying new things and figuring out new things. And that, I think that curiosity is well satiated by an entrepreneur's life. The managing your own psychology is really difficult, but that's why you have a great community of people around you, both within the entrepreneur community and outside of it. [00:25:36] Lindsey Dinneen: Oh my word. I think I just need to take what you just said those last couple of sentences and just make it into a quote because that was so well articulated. [00:25:45] Holly Rockweiler: Oh, thank you. [00:25:47] Lindsey Dinneen: I cannot think of a better way to describe that journey. So thank you for, but also thank you for being vulnerable and willing to share that, because it is such a journey and it is a learning curve, but kudos to you for embracing it with an attitude of fun, like, "Let's just learn something new and it might not go great the first time, but that's okay. I'll try again." [00:26:10] Holly Rockweiler: Yeah, I was thinking, I was like, "Well, if any of my investors are listening, I have gotten really good at a lot of these things, so y'all don't need to worry." But I do think that's maybe the blessing and the curse of being a first time entrepreneur. So I think, you know, there's certainly a lot of benefits for having done it before and knowing exactly what to expect. But I think with anything in maybe any regulated industry, or maybe any startup, really, there's always going to be curveballs. So that keeps you excited. [00:26:41] Lindsey Dinneen: it's never boring. It keeps you on your toes. There's at least that. [00:26:45] Holly Rockweiler: Yes, absolutely. [00:26:47] Lindsey Dinneen: Excellent. Pivoting the conversation just for fun. Imagine that you were to be offered a million dollars to teach a masterclass on anything you want. It can be within your industry, but it doesn't have to be. What would you choose to teach and why? [00:27:04] Holly Rockweiler: Oh, that's interesting too. And that's a nice paycheck. [00:27:08] Lindsey Dinneen: Right? I [00:27:10] Holly Rockweiler: Let's see. It's getting right to what do I think I'm good enough at to teach a class about. So, I mean, I think one thing that I've been thinking about a lot recently is scientific communication and how, how different voices get amplified and how the kind of stereotypical scientific persona is, it's not the one that wants to be necessarily on social media with a gazillion followers and all these TikTok videos. So I think that I would like to teach the class in concert with, I have a lot of ideas of like, who would be a great way, who would be great people to collaborate with in order to teach or really to help promote more scientific discourse in a conversation that's appropriate and approachable for anyone. [00:28:04] I think that obviously our country has faced a lot of division and I don't think that's really true. I think that a lot of that is-- well, there certainly is a lot of division. I don't mean that. I just mean that I think there's a path to human connection via communication and that, wouldn't it be cool if we could help bridge conversations. And obviously I'm, I am a scientist. I think of myself as a scientist, so I want to think about ways to provide other voices out there to be amplified as well, or perhaps amplify the right voices to help promote just a more enriched dialogue than what is often presented as the country's dialogue today. [00:28:48] Lindsey Dinneen: I love that. [00:28:50] Holly Rockweiler: It's kind of rambling. I can get back to you with my course description, but that's probably where I would go. [00:28:56] Lindsey Dinneen: Syllabi due Tuesday. No, I think that is absolutely incredible. And I love that because I think that is something that's missing and there's some translation error that occurs. And one of the things that I'm passionate about is helping to bridge that gap between-- so I'm right on board with you-- but to bridge that gap between maybe taking some what are traditionally considered complex ideas, concepts, whatever, and distilling it down to a more accessible format. And because everyone learns differently, it's just helpful to have a wider range of options. [00:29:35] Holly Rockweiler: Totally. [00:29:36] Lindsey Dinneen: So I love what you would be passionate about sharing. I mean, I would sign up for that masterclass. [00:29:41] Holly Rockweiler: You can help me teach it, I think. [00:29:43] Lindsey Dinneen: Okay. Deal. We'll get back on that. [00:29:45] Holly Rockweiler: Okay. [00:29:47] Lindsey Dinneen: Excellent. Yeah. How would you wish to be remembered after you leave this world? [00:29:53] Holly Rockweiler: You have some great questions. Yeah, let's see. You know, I've honestly never thought about that. I think that I would, what would I want people... well, I think about like what I would want my friends to think. That, like, they were loved and that they hopefully shared that love broadly. But then, well, let's see, that's not really, like, remembering. Yeah, I guess, maybe it is. So, yeah. That I'm a lover, a curious person, and that I, there is a lot of beauty in the everyday, and so there's a lot to be excited about even on the hard days, [00:30:32] Lindsey Dinneen: Yeah. I love that. And then, final question. What is one thing that makes you smile every time you see or think about it? [00:30:41] Holly Rockweiler: Certainly my family. I have a four year old son and he is, keeps me very present and cracks me up continuously. And so, my husband and I are very lucky to have him. And obviously my husband makes me laugh. A lot. And so I really appreciate them. And so even when, you know, the work day is hard, I feel really fortunate to have a very rich personal life outside of that. So my family and then my friends also. [00:31:09] Lindsey Dinneen: Oh, yes. Of course. That's wonderful. And I'm so glad you have that amazing support system to bring that smile to your face, especially on the tough days. [00:31:19] Holly Rockweiler: Absolutely. [00:31:20] Lindsey Dinneen: Well, Holly, this has been a wonderful conversation. I'm so thankful for you and what you're doing in this space and the fact that you're tackling an issue that affects so many people, and that you're just bringing all this innovation to, and you're so passionate about sharing that in a way that resonates with people. So I just want to first say, you know, thank you so much for the work that you're doing. I know it's not easy and there are probably days where you, you just kind of want to, you know, toss something in the trash, but honestly, thank you for continuing to do the work you're doing. It's not nothing. And I want to appreciate that. [00:31:59] Holly Rockweiler: Well, that is very kind. Thank you. And that means a lot. And thank you for doing what you're doing, too, to give people like me a chance to share, and also us to listen to others sharing their stories. And for asking, I will say, asking questions that are more about me as a whole person too. I think that when I've been in other conversations sometimes are really-- and there's nothing wrong with those, but it's fun to have, we can ask these questions. I'm like, "Wow, I would do some thinking this weekend about how I want to be remembered" because I've never thought about that. [00:32:30] Lindsey Dinneen: Yeah. There you go. I love it. Well, and we are so honored to be making a donation on your behalf as a thank you for your time today to the Equal Justice Initiative, which provides legal representation to prisoners who may have been wrongly convicted of crimes, poor prisoners without effective representation, and others who may have been denied a fair trial. So thank you for choosing that organization to support, and we just wish you continued success as you work to change lives for a better world. [00:32:59] Holly Rockweiler: Well, thank you. It's been a pleasure. Thank you. [00:33:03] Lindsey Dinneen: Me too. And thank you so much for our listeners for tuning in. And if you're feeling as inspired as I am right now, I would love if you would share this episode with a colleague or two, and we will catch you next time. [00:33:16] Ben Trombold: The Leading Difference is brought to you by Velentium. Velentium is a full-service CDMO with 100% in-house capability to design, develop, and manufacture medical devices from class two wearables to class three active implantable medical devices. Velentium specializes in active implantables, leads, programmers, and accessories across a wide range of indications, such as neuromodulation, deep brain stimulation, cardiac management, and diabetes management. Velentium's core competencies include electrical, firmware, and mechanical design, mobile apps, embedded cybersecurity, human factors and usability, automated test systems, systems engineering, and contract manufacturing. Velentium works with clients worldwide, from startups seeking funding to established Fortune 100 companies. Visit velentium.com to explore your next step in medical device development.

INTRODUCTIONJoin us for an insightful interview with Beatriz from Tocco, a Paris- and Singapore-based company at the forefront of biodesign. Tocco is revolutionizing the industry with the world's first AI-enabled B2B marketplace for regenerative and low-carbon materials. Their mission? To make it 10x easier and faster for brands to identify, benchmark, and procure cleaner materials, combating the plastics crisis head-on.In this episode,discover how Tocco acts as a bridge between suppliers and brands, providing comparable data on materials from their sources to their end of life;learn about the space they give to innovation, from lab stages to commercial success;and find inspiration in how they facilitate collaboration through transparency and trust.Finally, don't miss a peek into their five awards categories celebrating sustainability pioneers!Tune in to meet the regenerative materials of a cleaner tomorrow, today!RESOURCES MENTIONED IN THIS EPISODESuggested episodes from the Unboxing Your Packaging podcast (https://www.look4loops.com/podcast):The “Certifications Spotlight: Truths & Traps” series and the “Wild Waste” series (each audio clip is about one material and is created in collaboration with Mme & M. Recyclage)Episode 55: “[Certifications Spotlight Audio Clip 8] The OK Compost Certifications: Home & Industrial” with Love-Ese Chile of Regenerative Waste Labs https://www.look4loops.com/packaging-podcast/ep55-certifications-review-ok-compost-home-industrialEpisode 20: “How to grow your compostable packaging? Explore the wonder of mycelium!” with Meghan Olson of Ecovative Design https://www.look4loops.com/packaging-podcast/ep20-compostable-mycelium-mushroom-designThe burning question came from Frédérique Drouin of Myni in episode 46: “Water-free tablets and reusable bottles: Rethinking product and packaging pairing” https://www.look4loops.com/packaging-podcast/ep46-non-toxic-products-water-free-tablet-reusable-bottlesEpisode 34: “Designing plastic free: Why and what does it take?” with Sian Sutherland of A Plastic Planet https://www.look4loops.com/packaging-podcast/ep34-plastic-free-material-design-campaigns-platformThe recommended sustainable packaging online course “Develop circular packaging solutions” https://circulab.academy/courses/develop-circular-economy-packaging/The suggested Biodesign readings:Book → John Dewey (2018). Experience and nature. Editorial: New York: Dover Publications.‌Book → Solanki, S. (2018). Why materials matter: responsible design for a better world. Munich: Prestel.MA Biodesign, Central Saint Martins → https://www.arts.ac.uk/subjects/textiles-and-materials/postgraduate/ma-biodesign-csmProject on Structural Colours→ Emotional Iridescence: A Living Colour by Célina Camboni @celinacamboni⁠MA Biodesign @mabiodesign ⁠https://www.instagram.com/p/ChJ7V0guWXN/?img_index=1Book recommended by Beatriz: Schumacher, E.F. (1973). Small is beautiful: Economics as if People Mattered. New York, Ny: Harper Perennial. https://en.wikipedia.org/wiki/Small_Is_BeautifulTocco's specific links:Investor page > https://mk.tocco.earth/unboxing-investorsPavilions > https://mk.tocco.earth/unboxing-pavilionsMatterMind > https://tocco.earth/resources/Awards  > https://mk.tocco.earth/unboxing-tocco-AwardsWHERE TO FIND TOCCO AND BEATRIZ?The Tocco' s website: https://tocco.earth/Their Instagram: https://www.instagram.com/tocco.earth/Their LinkedIn: https://www.linkedin.com/company/toccoBeatriz LinkedIn profile: https://www.linkedin.com/in/ana-beatriz-alves-68a180113/ABOUT ANA BEATRIZ ALVES FROM TOCCOAna Beatriz Alves is a creative professional deeply entrenched in the realms of sustainable design and materials innovation. She graduated from University of Arts London: Central Saint Martins, with a Master's degree in Biodesign, Textile & Materials, where she explored the intricate relationship between design and environmental responsibility. With her current role as a Materials and Climate Founder Associate at tocco, Beatriz shapes the brand's design philosophy, regenerative design communication, and overall impact frameworks. Beatriz's material research was lately demonstrated through her Blue Yonder project, showcased at the Eindhoven Dutch Design Week 2022. Blue Yonder explored the potential of algae biodegradable plastics, highlighting innovative solutions to environmental challenges in design. The project was recognized by LVMH, and chosen as a shortlisted project for the Grand Prix LVMH MA biodesign in 2022.PODCAST MUSICSpecial thanks to Joachim Regout who made the jingle. Have a look at his work here. I am happy to bring a sample of our strong bonds on these sound waves. Since I was a child, he made me discover a wide range of music of all kinds. I am also delighted he is a nature lover and shares the Look4Loops 'out of the box philosophy'. He is an inspiring source of creativity for me. 

Join host Doug Shapiro "In the ROOM" LIVE from ICFF 2024.  In this two-part series, Doug explores the unique energy and innovation at ICFF - featuring insightful conversations with industry leaders such Amy Devers, Luca Nichetto, and Giulio Cappellini, listeners will hear inspiring stories, fresh perspectives, and valuable advice. Highlights include Amy Devers, discussing the importance of student work and the evolving role of materials, Luca Nichetto's take on balancing tradition with innovation, and Giulio Cappellini's humorous anecdote about Queen Elizabeth II. Let's escape the noise and join us "In the ROOM."Learn more about ROOM. Follow Doug on LinkedIn.Click here to get your copy of Doug's children's book—Design Your World.Follow Imagine a Place on LinkedIn.

Jonathan is joined by Joshua Makower, Director and Co-Founder of the Stanford Byers Center for Biodesign, Stanford University, California, USA. The pair navigate fascinating themes, from Makower's passion for music and his band, Still Trust, to innovative strategies for controlling rising healthcare costs through innovation. Makower offers perspectives on AI in healthcare, and the associated challenges with regulating these new technologies. Use the following timestamps to navigate the topics discussed in this episode: (00:00)-Introduction  (03:05)-A passion for music  (06:11)-From the Massachusetts Institute of Technology (MIT) to medical school  (08:50)-The Biodesign process  (19:37)-Driving technology from mind to marketplace  (23:25)-Doctors engaging with industry  (27:52)-The ExploraMed incubator  (31:07)-Josh's current work  (34:27)-The importance of failure  (36:16)-Perspectives on artificial intelligence in healthcare  (39:05)-Healthcare innovation horizons  (40:37)-Medical technology regulation  (46:00)-Josh's three wishes for the future of healthcare 

“You can be successful as an innovator, even as a physician or any other background you have, as long as you follow the process and really focus on the needs. That's the key.” - Dr Josh Makower, Director and Co-Founder of the Stanford Byers Center for Biodesign.In this episode, Dr Joshua Makower discusses his newest medical device approval "Moximed" and how his multi-disciplinary education of engineering, medicine and business has supported his successful career as an inventor. He goes on to highlight how clinicians and healthcare systems need to embrace innovation to solve some of our biggest challenges. Dr Makower puts forward how lessons working on innovation at Pfizer influenced the Biodesign approach to innovation. Finally, he covers the policy and investment landscape for progressing healthcare innovation.Follow Dr Makower* Twitter/X* LinkedInAbout the guest:Josh Makower, MD is the Boston Scientific Applied Bioengineering Professor of Medicine and of Bioengineering at the Stanford University Schools of Medicine and Engineering, and is the Director and Co-Founder of the Stanford Byers Center for Biodesign, and Founder of Stanford's Biodesign Policy Program.  Josh also serves as a Special Partner on New Enterprise Associate's healthcare team supporting their medtech/healthtech practice.  Lastly, Josh is the Founder and Executive Chairman of ExploraMed, a medical device incubator that has created 10 companies over the past 20 years. Josh currently serves on the board of directors for DOTS Devices, ExploraMed, Allay Therapeutics, Lungpacer, Moximed, Willow Innovations, SetPoint Medical, X9 and Coravin. Josh holds over 300 patents and patent applications for various medical devices in the fields of cardiology, ENT, general surgery, drug delivery, plastic surgery, dermatology, aesthetics, obesity, orthopedics, women's health and urology.Additional resources mentioned in the podcast:* Moximed* Biodesign at Stanford* Book - Biodesign: The Process of Innovating Medical TechnologiesContact Information for the Podcast: If you have any feedback, questions or if you'd like to get in touch, reach out at jono@clinicalchangemakers.comIntro and Out Music Attribution: Music by AudioCoffee from Pixabay This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.clinicalchangemakers.com

Un grupo de alumnos de diferentes carreras ha logrado impulsar este proyecto, bajo el marco del curso BioDesign, organizado por Tecnun y el Laboratorio de Ingeniería Biomédica. Cristina del Molino, una de las artífices del simulador, nos cuenta más detalles.

This episode features Bob Rebitzer, National Advisor, Manatt Health & Senior Advisor, Stanford Byers Center for Biodesign & Jim Rebitzer, Peter and Deborah Wexler Professor at Boston University's Questrom School of Business. Here, they discuss insights into their backgrounds & new book they've co-authored “Why Not Better and Cheaper? Healthcare and Innovation”, advice for healthcare leaders looking to innovate, and more.

Integrating biodesign principles can drive innovative breakthroughs in medical device technology. But what exactly is biodesign, and how can medtech companies utilize it to drive innovation?On this week's Medical Alley Podcast, Greg Johnson of Veranex and Todd Brinton of Edwards Lifesciences join to share more about biodesign and how they've utilized it at their respective organizations. Both have experience the Stanford Byers Center for Design, which was co-founded by former Medical Alley Podcast guest Josh Makower.Tune in to learn more about the concept of biodesign — a structural process for thinking about innovation — and hear Greg and Todd share their visions for the future of biodesign in medtech.Follow Medical Alley on social media on LinkedIn, Facebook, Twitter and Instagram.

Episode Description: Karl and Erum engage with Natsai Chieza, visionary leader at Faber Futures, to navigate the evolving landscape of biodesign where the organic intricacies of biology meet the transformative capabilities of technology. We delve into the nuances of integrating bioproducts seamlessly into everyday life, reflect on the renewed appreciation for nature's intrinsic value in our post-pandemic world, and highlight the pioneering strides made by Ginkgo Bioworks. Together, we dissect the intricate process of scaling biotechnological innovations and share the enchanting narrative of crafting with bio pigments. Embark on this exploration with us as we reveal the art of harnessing life's designs, confront the pressing demands of the climate emergency, and envisage the burgeoning trajectory of the bioeconomy. Grow Everything brings to life the bioeconomy when hosts Karl Schmieder and Erum Azeez Khan share stories from the field and interview leaders and influencers in the space.  Life is a powerful force and it can be engineered. What are we creating? Learn more at www.messaginglab.com/groweverything Topics Covered: 00:00:00 - Dive into Biodesign with Natsai Audrey Chieza 00:02:14 - The Green Thread: Biotech's Role in Sustainable Manufacturing 00:04:35 - The Aesthetics of Biology in Architectural Design 00:06:58 - Textiles and the Environment: A Biotech Perspective 00:09:12 - The Wonders of Biomanufacturing Explored 00:11:46 - The Growth of Natsai's Biodesign Vision 00:14:02 - Bridging Disciplines for Breakthrough Innovations 00:16:25 - Biology as the Core of Creative Product Design 00:19:33 - The Craft and Science Behind Biofabrication 00:22:47 - Biotech's Role in Shaping Daily Experiences 00:25:05 - The Dynamic World of Biotech Entrepreneurship 00:27:53 - Ethical Considerations in Biotech Advancements 00:30:18 - Audience Insights: Merging Art with Biotechnological Science 00:34:01 - Biology's Disruptive Influence on Business Norms 00:37:29 - From Concept to Commerce: Biotech's Path to Market 00:40:11 - Overcoming Obstacles in Biotech Scale-Up 00:42:50 - Balancing Economy with Eco-Friendly Biotech Practices 00:45:11 - Building a Greener Biotech Supply Chain 00:47:52 - The Fusion of Design and Biology in Biodesign 00:50:48 - Debating Biotech's Value Proposition and Reach Episode Links: Website World Economic Forum Faber Futures (company site) Normal Phenomenon of Life (company site) Ginkgo Bioworks (company site) Natsai Chieza (LinkedIn) World Economic Forum Synthetic Biology (council site) Have a question or comment? Message us here: Text or Call (804) 505-5553 Instagram / TikTok / Twitter / LinkedIn / Youtube / GrowEverything website Email: groweverything@messaginglab.com Support here: Patreon Music by: Nihilore Production by: Amplafy Media --- Send in a voice message: https://podcasters.spotify.com/pod/show/messaginglab/message

"The reality is, and the catchy way to remember it is, 'If it needs a sign, it's bad design.' You see a teakettle, and you immediately know how to use it. " —Gregory Khodorov, MD, MBAAs part of a new series from the SIR Medical Student Council (MSC) Biodesign Committee, hosts Eleanor Lee, MPH, and Savraj Saggu speak with Gregg Khodorov, MD, MBA, on identifying problems to solve in interventional radiology, how to recognize bad design and more.Note: Submissions for the committee's next biodesign competition will be due on Jan. 15, 2024. Watch for more details in the SIR Connect RFS Community. Related resources:Competition themeRegistrationSyllabus(c) Society of Interventional Radiology.Support the show

Explore the groundbreaking world of molecular protein engineering with Scala Biodesign as they employ the power of AI to revolutionize this critical field. Join us in this episode to unravel how AI technologies are reshaping protein engineering and uncovering new opportunities in biodesign. Learn how Scala Biodesign is at the forefront of this AI-driven transformation, pushing the boundaries of what's possible in molecular research. Get on the AI Box Waitlist: https://AIBox.ai/Join our ChatGPT Community: ⁠https://www.facebook.com/groups/739308654562189/⁠Follow me on Twitter: ⁠https://twitter.com/jaeden_ai⁠

In this episode, we unveil a game-changing approach in biodesign as Scala Biodesign harnesses the power of AI for molecular protein engineering. Discover how this cutting-edge technology is revolutionizing the field, enabling breakthroughs in drug development, healthcare, and beyond. Join us for an illuminating discussion on the transformative potential of AI in the realm of biotechnology. Get on the AI Box Waitlist: https://AIBox.ai/Join our ChatGPT Community: ⁠https://www.facebook.com/groups/739308654562189/⁠Follow me on Twitter: ⁠https://twitter.com/jaeden_ai⁠

For the future of sustainable textiles, should we look no further than … the ocean? Today we're speaking with Aleks Gosiewski and Tessa Callaghan, the founders of Keel Labs, a sustainable materials company built on regenerative principles. Keel Labs' signature product is Kelsun, a seaweed-based yarn with a significantly lower environmental footprint than traditional fibers. Alex and Tessa met as design students at the Fashion Institute of Technology and went on to win the first-ever Biodesign Challenge in 2016. In the years since they founded Keel Labs, both women have been named as one of Forbes' 30 Under 30. In this episode, we chat with Tessa and Aleks about the promise of kelp as a regenerative raw material, the process of turning kelp into a functional textile, and we dive into - no pun intended - the challenges and rewards of building a company with sustainable innovation at its very core. Show NotesKeel LabsForbes' 30 Under 30 2022 (Manufacturing)Would You Wear a Sweater Made Out of Seaweed? (HighSnobiety)A new material made from seaweed will transform the entire textile industry by Tessa Callaghan (Upworthy)Keel Labs on Instagram, Twitter, YouTube, TikTok, LinkedInFashion Institute of Technology (FIT)The Biodesign ChallengeKey Words: Keel, Keel Labs, Ocean, Seaweed, Kelp, Algae, Fashion, Design, Fashion Design, Textiles, Materials, Sustainability, Regenerative, Regenerative Materials, Environment, Climate, Climate Change, Climate Solutions, Biophilia, Biophilic Design, Biodesign 

Today on Mushroom Hour we are blessed once more by the presence of Mycomaterial Specialist Ashley Granter. Along with Biofashion Designer Aurelie Fontan, Ashley is a founder of Osmose Studios - a multidisciplinary design studio dedicated to exploring how society should draw inspiration and processes from Mother nature. Working with mycelium as well as natural dyes and fabrics, they aim to bring forward beautiful design that doesn't cost the planet and actually fosters the regeneration of lost ecosystems.    TOPICS COVERED:   Birth of Osmose Studios    Working with Classic Biomaterials in New Ways    Fashion, Materials, Regenerative Design    Future of Biomaterials Rooted in Technologies of the Past?   Product Design Grounded in Consumer Experience    Dresses Made with Kombucha & Mycelium Leather   Interior Design made with Mycelium    Diverse Landscape of the Biomaterials Industry    Scaling Sustainably and Decentralized – like a Fungus   Integrating Waste Streams into New Materials    Genetic Modification vs Directed Evolution    Business' Role in Preserving Ecosystems and Biodiversity   Biomaterials as a Craft vs Mass Production   Working with Your Life Partner as a Business Partner    EPISODE RESOURCES:   Osmose Studio IG: https://www.instagram.com/osmose_labs/   Armillaria (fungal genus): https://en.wikipedia.org/wiki/Armillaria   Cantharellus (fungal genus): https://en.wikipedia.org/wiki/Cantharellus   Francis Crick's books: https://www.thriftbooks.com/a/francis-crick/219274/   "Synthetic Aesthetics" by Alexandra Daisy Ginsberg: https://www.daisyginsberg.com/work/synthetic-aesthetics-book    

In this episode, we dive into the fascinating world of Scala Biodesign and how it leverages artificial intelligence to simplify the complex process of re-engineering proteins at the molecular level. We explore the implications of this technology for healthcare, manufacturing, and beyond. Get on the AI Box Waitlist: ⁠https://AIBox.ai/⁠ Facebook Community: ⁠⁠https://www.facebook.com/groups/739308654562189/⁠⁠ Discord Community: ⁠https://aibox.ai/discord⁠ Follow me on X: ⁠https://twitter.com/jaeden_ai⁠

There's a gold rush on in biotech as AI and other tools are used to find new drugs and treatments. With $5.5 million in new funding,

CardinalKit (now Spezi) is an open-source framework for Digital Health Applications and Research. They were recently featured in the news for releasing HealthGPT, an experimental iOS app that lets you query your health data. Spezi is housed in the Stanford Byers Center for Biodesign and directed by Oliver Aalami, MD with Vishnu Ravi, MD as lead architect. Also joining us on this interview is postdoc Paul Schmiedmayer, PhD. Spezi provides a suite of tools to build modern, interoperable digital health tools from the ground up, from the app itself to storing and analyzing collected data in the cloud. It is designed to accelerate rapid prototyping of digital health applications by reducing costs by as much as 75% (~$150,000) and timelines by 12 months. Host: David Wu Twitter: @davidjhwu  Audio Producer + Video Editor + Art: Saurin Kantesaria Instagram: saorange314 Social Media: Nikhil Kapur Time Stamps: 00:58 - The expertise behind Spezi (CardinalKit) 08:03 - Healthcare has a lack of data standardization + Why you should know about HL7 FHIR 14:13 - How did Spezi (CardinalKit) become what it is today? 18:26 - Drink Spezi! 19:53 - Making code/healthcare data more modular and user-friendly 26:40 - Translating a med student's sensor research to a useable device for kids with cerebral palsy 31:20 - From a $40,000 eczema patch test in clinic to a completely at-home test 35:45 - Using healthGPT to make health data easy to understand for patients (LLM on FHIR) 42:35 - How do you deal with privacy issues? 49:33 - What do you think the future of AI in medicine will look like in 10-20 years? 52:00 - Applications where using only an LLM doesn't always work (a case for hybrid systems) 55:30 - What brings you joy? 58:43 - What makes a successful digital health team?

Dr. Josh Makower is a Professor of Medicine & Bioengineering at Stanford University and is also the Director & Co-Founder, Stanford Byers Center for Biodesign. He joined this week's Medical Alley Podcast for a wide-ranging conversation. Dr. Makower joined Medical Alley's Frank Jaskulke to discuss his Perfect Storm presentation, share more about the importance of policy work with regards to healthcare innovation, talk about the Stanford Biodesign program, and much more.

This episode is sponsored by @MedicalExpertWitness.com.  The episode features Dr. Al'ai Alvarez discussing the Stanford Fulfillment Model and its relevance to medical practices. Dr. Alvarez shares his training experience and how he ended up at Stanford. He highlights the three key aspects of the Stanford professional fulfillment model: culture of wellness, efficiencies of practice, and personal resilience. The discussion revolves around the importance of creating an environment that fosters autonomy, belonging, and competence, as well as the need for meaningful efforts from institutions to support clinicians' professional fulfillment. Looking for something specific? Here you go! 00:03:29 Stanford fulfillment model promotes professional fulfillment. 00:05:41 Responsibility for burnout lies with institutions. 00:11:03 Physicians experience imposter phenomenon. 00:17:11 Normalize self-care in medicine. 00:21:28 Recognize and value team contributions. 00:28:40 Practice self-compassion and gratitude. 00:33:01 Self-compassion is essential for resilience. 00:36:28 Practice self-compassion and celebrate achievements. 00:42:44 Intersection of wellness and DEI. Bio/links! Al'ai Alvarez, MD, is a prominent national leader and educator in wellness, diversity, equity, and inclusion. He holds the position of Clinical Associate Professor of Emergency Medicine (EM) and serves as the Well-Being Director at Stanford Emergency Medicine. Dr. Alvarez's focus lies in humanizing physician roles and teams, harnessing individual human potential within high-performance contexts by optimizing the connections between Process Improvement, Recruitment, and Well-being. He is also associated with the Stanford Byers Center for Biodesign as a 2021-2022 Faculty Fellow. Previously, Dr. Alvarez served as an associate program director in the Stanford Emergency Medicine Residency Program for five years, emphasizing the intersectionality of resident well-being with performance improvement, patient experience, quality and safety, diversity, equity, inclusion, and medical education. His contributions include co-founding the largest diversity mentoring initiative in Emergency Medicine through ACEP and EMRA. Additionally, Dr. Alvarez chairs Stanford WellMD's Physician Wellness Forum and directs Stanford's Physician Resource Network (PRN) Support Program, offering vital peer-to-peer support for faculty and trainees. As a sought-after speaker, he delivers grand rounds and lectures at national conferences, addressing self-compassion, physician well-being, high-performance teams, leadership capacity, and mentorship to enhance diversity and inclusion. Dr. Alvarez's remarkable dedication and contributions have earned him prestigious awards, such as the 2019 ACEP DIHE Distance and Impact Award and the 2022 John Levin Leadership Award at Stanford Health Care. Connect with Dr. Alvarez on his LinkedIn.  Did ya know…  You can also be a guest on our show? Please email me at brad@physiciansguidetodoctoring.com to connect or visit www.physiciansguidetodoctoring.com to learn more about the show! Socials: @physiciansguidetodoctoring on FB  @physicianguidetodoctoring on YouTube @physiciansguide on Instagram and Twitter

This week we interview Nick Damian. Nick is a serial entrepreneur focused on solving unmet needs to improve patient care. He is currently CEO & Founder of Andromeda Surgical, which is developing autonomous robots for safer, better, more efficient surgery. Before that, he was CEO & Co-Founder of Zenflow, where he co-invented a novel implant for BPH (enlarged prostate) and led the product from inception through multiple clinical trials to commercial readiness, raising over $60M in funding. He was also CTO & co-founder at Nurep, later re-branded as Avail MedSystems. He was the key architect of the company's remote surgical support product for operating rooms that is now used in hundreds of medical facilities. Nick earned his M.S. and B.S. with Distinction in Management Science & Engineering from Stanford University and was an Innovation Fellow at Stanford Byers Center for Biodesign. He was the first medtech founder to be funded by Y Combinator twice and actively advises startups through StartX, UCSF Rosenman Institute, and Nucleate Bio. He also dabbles on the investor side as a Venture Partner at Pioneer Fund.

In this episode, we dive deep into the world of biodesign, exploring the amazing opportunities that arise when science, technology, and fashion come together. Think faux leather that's made with kombucha, functional yarn derived from seaweed, and performance clothing that replaces nylon and spandex with naturally sourced, biodegradable protein. Our guest is Dr. Karen Pearson, Professor of Chemistry at the Fashion Institute of Technology (FIT) and Chair of FIT's Sustainability Council. Karen has been widely recognized for her commitment to cross-disciplinary education: she is the recipient of the President's Award for Curricular Innovation and has been acknowledged as one of the top 100 Most Influential Women in STEM. In this episode, we discuss the intersection of science and design, the innovative work being done by FIT students and faculty, and talk through some amazing examples of biodesign in action. Show NotesFashion Institute of Technology (FIT)Sustainability at FITNatural Dye Garden ProjectBiodesign ChallengeKeel LabsWerewoolKey Words: Biophilia, Biophilic, Biophilic Design, Biodesign, Biotechnology, Biology, Chemistry, STEM, STEAM, Fashion, Fashion Institute of Technology, Technology, Design, Fashion Design, Materials, Innovation, Sustainability, Sustainable, Climate Change, Climate, Nature Based, Nature Based Solutions  

Currently, the world makes over 460 million tons of plastic per year, a number that is set to grow as fossil fuels companies are increasingly turning to plastic production for profits. The problem is only 2% of plastics are ultimately recycled. Epoch BioDesign is looking to change that by using synthetic biology and AI to develop enzymes that eat plastic and can be turned into chemicals. Jacob Nathan is the CEO of Epoch BioDesign. At age 18, he started the company alongside British biochemist, Professor Douglas Kell, when he discovered microbes capable of breaking down plastic waste during a senior research project. Since then, the company has grown tremendously, and in June 2022, Epoch announced an $11m seed fundraising round. In this episode we cover... What inspired Jacob to start Epoch How enzymes fundamentally work Machine learning and AI's role in Epoch's process The chemicals that Epoch is looking to develop The problems with our current recycling and chemical production processes Epoch's path to monetization Challenges facing Epoch as they scale What Jacob has learned in the founding process Jacob, the master scuba diver Connect with us: Instagram | Twitter | LinkedIn Episode Recorded on May 25, 2023

Janene H. Fuerch, MD is a Clinical Assistant Professor of Neonatology at Stanford University Medical Center, as well as an innovator, educator, researcher and physician entrepreneur. She has an undergraduate degree in Neuroscience from Brown University and a medical degree from the Jacobs School of Medicine at SUNY Buffalo. At Stanford University she completed a pediatrics residency, neonatal-perinatal medicine fellowship and the Byers Center for Biodesign Innovation Fellowship. She is the Assistant Director of the Stanford Biodesign Faculty Innovation Fellowship, Assistant Director for the UCSF-Stanford Pediatric Device Consortium funded by the FDA and core faculty at the Center for Pediatric and Perinatal Education or CAPE (a specialized simulation center at Stanford). Janene is the co-founder of Emme - a women's reproductive health company acquired by SimpleHealth in 2022. "Our mission is to put women's health in women's hands. We're starting with the birth control pill, because missed pills, hormone imbalance, and unplanned pregnancy are all too common parts of the pill experience."

SD193 - Sistema de Saúde Norueguês. Neste episódio, Dr. Lorenzo Tomé recebe a médica pediatra, Dra. Caroline Kanaan, para contar sobre a sua experiência pessoal com o sistema de saúde da Noruega, os diferenciais e sobre inovação na saúde. Caroline atua como emergencista pediátrica no Hospital Albert Einstein e é a coordenadora do programa Einstein Biodesign. Dica do Lorenzo: clique para conhecer e seguir a Futuro da Saúde! Participe da nossa Comunidade de Cardiologia CardioGram! Acesse AQUI. Neste episódio, o que você vai encontrar: O Background da Caroline Sua trajetória profissional começou fazendo gradução em moda e estagiando em grandes empresas do setor. O maior impacto foi na empresa de consultoria WGSN onde teve contato com a ideia de inovação e relevância no mercado. Depois Caroline fez medicina, especializou-se em pediatria, trabalhou um tempo fora do Brasil até assumir no Hospital Israelita Albert Einstein. O médico e a inovação Sobre o médico: "...eu só sei trabalhar na assistência ou como docente ou como pesquisador. Os médicos, eles ainda não entendem o potencial que nós temos né (sic) pra trazer novas visões, pra trabalhar com inovação, tecnologia que de fato impactem na saúde do paciente muito mais do que o que a gente tem de impacto só na assistência." O sistema da Noruega Sistema de saúde público que funciona muito bem e um dos melhores avaliados no mundo; Integração no cuidado do paciente; Interoperabilidade dos dados muito eficaz, de fácil acesso e com assinatura digital; Pacientes não fazem a passagem pela UTI,  se não houver intercorrências ele vai direto para o quarto; Integração entre médicos e enfermagem: equipe de enfermagem extremamente capacitada, autônoma. Custo do sistema de saúde O governo subsidia grande parte do sistema, tanto para o estrangeiro quanto para sua população que não tem custo algum. Médico na inovação "...quando a gente tem um médico trabalhando na inovação, é preciso repensar aquela estrutura que nós tínhamos na assistência. Na inovação, os outros não estão a serviço do médico, estão todos, incluindo o médico, a serviço da inovação..." Inovação no Einstein Incubadora e aceleradora Eretz Bio; Health Innovation Tech Center; Laboratório de metologias de inovação com o programa Biodesign; Braço de Venture Capital. O Programa Biodesign Metodologia de inovação que foi criada por Stanford há cerca de 21 anos como uma releitura do Design Thinking. O programa tem 3 fases: identificação de necessidades não atendidas; invenção de uma solução e depois a fase de implementação da inovação criada. Comunidade Online Saúde Digital Podcast Você é médico? Quer interagir com o Lorenzo Tomé e com outros colegas inovadores da medicina digital?  Entre na Comunidade do Podcast Saúde Digital na SD Conecta! Assista este episódio também em vídeo no YouTube no nosso canal Saúde Digital Ecossistema! ACESSE AQUI! Episódios Anteriores - Acesse! SD192 - Médico Brasileiro na Copa do Mundo do Catar SD191 - Software para engajamento e gestão de pacientes SD190 - Influência Digital na Pediatria Músicas | Declan DP - Island "Music © Copyright Declan DP 2018 - Present. https://license.declandp.info | License ID: DDP1590665"

Meet Josh MakowerJosh Makower, M.D., is the Boston Scientific Applied Bioengineering Professor of Medicine and of Bioengineering at the Stanford University Schools of Medicine and Engineering, and is the Director and Co-Founder of the Stanford Byers Center for Biodesign, and Founder of Stanford's Biodesign Policy Program. Key Insights:Josh holds over 300 patents, and believes that innovation is a process than can be taught.  How to improve global health? Josh believes that innovation can be learned deliberately, and that those who practice it according to his process, will get good at it. Two Modes. The innovator must first consider all possibilities, even “wild ideas,” and then switch gears, to identify dead ends as rapidly as possible. Teaching Policymakers. In addition to teaching aspiring innovators, Josh believes that educating the next generation of policymakers is a crucial undertaking. This episode was made possible by our partnership with Edwards Lifesciences. Relevant Links:Read more about Josh MakowerRead more about Stanford's Biodesign Policy Program

In today's episode, we are joined by Jacob Nathan Co-Founder & CEO of Epoch Biodesign. Jacob sat down with our host Sina Sadrzadeh, Co-Founder of Wing and discussed what it's like being a young entrepreneur.  Listen to Jacob speak about his business and how it is helping to solve the most pressing issues in climate tech.  For more information about Elevating Founders, go to: www.elevatingfounders.tech Interested in attending London Tech Week 2023? Go to: londontechweek.com

Today on Mushroom Hour we have the opportunity to speak with Maurizio Montalti. Maurizio Montalti is a designer, researcher, educator and entrepreneur. Working at the junction of design and biotech, he is one of the early pioneers committed to the study and development of wide-ranging mycelium-based technologies and products. Maurizio is Chief Mycelium Officer, Chairman, and co-Founder of SQIM, the (bio)technology company developing innovative processes and products by unravelling the potential of mycelium as key biofabrication agent and technology, for application and use across different industries, as fundamentally rooted in the valorisation of residual materials' streams by means of microbial fermentation. As (bio-)technological holding, today SQIM serves its two verticals/brands: MOGU (biomaterials/products dedicated to interior design and architecture) and EPHEA (biomaterials/products dedicated to fashion, automotive, etc.). Maurizio's work has been honoured with multiple awards, widely featured in the global media, and exhibited worldwide in prestigious musea, galleries, and institutions, including Museum of Modern Art (New York), Centre Pompidou (Paris), Design Museum (London), Triennale (Milano), MAXXI (Rome), and MAK- Museum of Applied Arts (Vienna), among others.   TOPICS COVERED:   Into the Spiraling Vortex of Mycelium   From Degradation of Waste to Regenerative Materials   Mogu Acoustic Collection   Selecting Fungal Species & Strains as Materials   Standardizing Unpredictable Myco-Materials   Can Organisms Retain Agency when Enlisted to Human Scientific and Economic Endeavour?   Wild Genetic Variation within Fungal Species   Fungal Strains SQIM Collaborates With   Becoming Fluent in the Language of Fungi    Living Buildings & Autonomous Biowelding   “Ephea” Leather and Fabric Product Lines   Scaling SQIM & Modular Mycelium Production   Circular Production Processes, Seeing Waste as a Resource   Fungi in Space   EPISODE RESOURCES:   Mogu Website: https://mogu.bio/   Mogu IG: https://www.instagram.com/mogumycelium/   Fungal Architecture Project: https://www.fungar.eu/   Officina Corpuscoli: https://www.corpuscoli.com/   Schizophyllum commune (AKA Split Gill Mushroom): https://en.wikipedia.org/wiki/Schizophyllum_commune   "Braiding Sweetgrass": https://milkweed.org/book/braiding-sweetgrass   "Designs for the Pluroverse": https://www.dukeupress.edu/designs-for-the-pluriverse   "Mushroom at the End of the World": https://press.princeton.edu/books/paperback/9780691220550/the-mushroom-at-the-end-of-the-world   

Audible Bleeding editor Wen (@WenKawaji) is  joined by JVS-VS Associate Editor Dr. Jose Diaz, JVS Assistant Editor Dr. Paul Dimuzio (@pdimuziomd) , and JVS Editor-in-Chief Dr. Thomas Forbes (@TL_Forbes) to discuss two great articles in the JVS family of journals.  They're joined by Dr. Oliver Aalami and Dr. Terence Ryan, authors of each of the papers discussing SVS supervised exercise therapy and two proteins (S100A8 and S100A9) that play an integral role in the ischemic limb pathophysiology.  “Use of an app-based exercise therapy program including cognitive behavioral techniques for the management of intermittent claudication” by Aalami et al. “S100A8 and S100A9 are elevated in chronically threatened ischemic limb muscle and induce ischemic mitochondrial pathology in mice” by Ryan et al. Show Guests: Dr. Oliver Aalami (@DrAalami) is a clinical professor of surgery at Stanford University. He is also the director of Stanford Byers Center for Biodesign since 2018.  Dr. Terence Ryan (@TerenceRyan_PhD) is an assistant professor on tenure track in the department of applied physiology and kinesiology at the University of Florida. Dr. Ryan's work focuses on understanding the molecular pathways that regulate muscle and vascular responses to environmental and endogenous stressors.    Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and #jointheconversation.

Over the past few years, we have seen a surge in the adoption of AI-powered solutions in various aspects of healthcare, from administrative tasks to clinical decision support. But one area where AI is starting to shine is in the operating room. From real-time image recognition to improved surgical planning and execution, AI is revolutionizing surgery and changing the way we think about operating rooms of the future.  In today's episode, Tommy talks with Nathaniel Smith and Dr. Derek Amanatullah, Founders of nSight Surgical. Dr. Derek Amanatullah is an orthopedic surgeon who specializes in hip and knee replacements for individuals with osteoarthritis, rheumatoid arthritis, infectious arthritis, and avascular necrosis. Nathaniel Smith is a designer who focuses on the overall environment, products, experiences, and brands. At nSight, Nathaniel and Derek are designing a better way to do surgery by using computer vision and artificial intelligence to decode what is happening in the operating room.  Tommy talks with Nathaniel and Derek about how they came together to fix what's broken in surgery and make it better. Key Takeaways [03:29] - What inspired Derek to become an orthopedic surgeon. [06:48] - What motivated Derek to study Biodesign. [10:07] - Nathaniel's career history in product design. [19:02] - How Nathaniel and Derek work together to fix surgery's broken system. [23:45] - Why hospitals should spend money on efficiency. [26:02] - What can be done to fix the broken communication pipeline in surgery. [29:53] - How Derek and Nathaniel are now fixing surgery's communication problems.   Quotes [07:07] - "I spent a month watching other people do surgery. And I found out that there are some fundamental problems in the communication pipeline of surgery that make it unsafe." - Derek Amanatullah [10:56] - "I started my career figuring out how to build a company from the ground up and manufacture goods in Southeast Asia. And that taught me how to develop new processes and manufacturing pipelines that worked well." - Nathaniel Smith [17:17] - "Our surgeries should not be managed with a dry-erase board and a pen. They shouldn't be managed with only manual processes with people talking across the room. It's clear that there are very easy to apply solutions in these environments, and there's a right way to do it." - Nathaniel Smith Links  Nathaniel Smith on LinkedIn Derek Amanatullah on LinkedIn nSight Surgical Connect with our hosts Mammoth Tommy on LinkedIn Subscribe and stay in touch Apple Podcasts Spotify Google Podcasts Learn more about Mammoth Scientific's Health & Tech Fund 1 When you move beyond the point of making sure your retirement goals are on track, your investment opportunities are wider than just publicly traded funds. Step into the world of investing in venture capital by learning more about Mammoth Scientific's Health & Tech Fund 1. Curated by some of the leading medical and fintech experts, Mammoth's Fund 1 is paving the way for health science and tech innovation. If you're interested in helping patient care, provider insight, and instrumentation go beyond possibility and into reality, check it out today at Mammoth.vc. Visit Mammoth.vc today!

Today's guest is Jacob Nathan, CEO and Co-Founder of Epoch Biodesign.Plastics are among the most visible and ubiquitous environmental issues plaguing Earth today. Hundreds of millions of tons of plastics are produced every year, but they weren't mass produced until after World War II (that's just one human lifetime ago). As a byproduct of the fossil fuel industry, plastics contribute significantly to the value of a barrel of oil, they create considerable emissions when produced, and they release carbon into the atmosphere when they are incinerated at the end of their lifecycle. So while plastics are a key building block of our modern world, they're also very problematic. Epoch Biodesign is on a mission to scale and industrialize biology to solve the world's biggest climate challenges, starting with an enzyme that eats plastic and converts it to industrial chemicals. The company is currently working with unrecyclable plastics that would otherwise go to landfill or incineration. The resulting molecules from their unique biological process can be used to create new products like adhesives, cleaning products, and fertilizers. In today's episode, we cover: An overview of plastics, their origin, widespread uses, and impacts on the environmentPlastics and the fossil fuel industryProblems associated with recycling End of life pathways most plastics take Epoch Biodesign's solution to addressing the plastic problem How enzymes can break down plastics and convert them into useful chemicals with a reduced carbon footprint The company's cell-free fermentation process and target outputs CO2 emissions associated with producing and incinerating plastic chemicals The origin of Epoch Biodesign Jacob's background and how he met his Co-Founder, Douglas Kell Douglas Kell's extensive background in systems biology, machine learning, etc. How Epoch Biodesign uses machine learning and tooling to design a computing platform for plastic-eating enzymes Future applications of the company's proprietary methods of designing biology How Epoch Biodesign's software enables them to scale and solve climate problems fasterThe company's business model Adjacent opportunities including textiles Epoch Biodesign's seed round and future financing Who Jacob wants to hear from and open positions at Epoch BiodesignEnjoy the show!You can find Cody on Twitter @codysimms, @mcjpod (podcast) or @mcjcollective (company). You can reach us via email at info@mcjcollective.com, where we encourage you to share your feedback on episodes and suggestions for future topics or guests.Episode recorded July 15, 2022.

In this HCI Podcast episode, Dr. Jonathan H. Westover talks with Dr. Anthony Harris about how businesses can have workplace safety within the realm of new COVID strains and mandates. See the video here: https://youtu.be/5_ve0DO2ocU. Dr. Anthony Harris, M.D., M.B.A., M.P.H., (https://www.linkedin.com/in/harrisan/) is the Owner of HFit Health and the former Chief Innovation Officer and Medical Director for WorkCare. He is board-certified in occupational and environmental medicine. Dr. Harris is the former medical director of Community Occupational Medicine, LLC. He has worked as a healthcare consultant with a focus on market research, product design and business development since 2006. Dr. Harris earned his medical and Master of Business Administration degrees at the Indiana University School of Medicine and Kelly School of Business, and his Master of Public Health degree at the University of Illinois, Chicago. He has general surgery training, and he completed fellowship training in Biodesign and Innovation at the University of Missouri. Please leave a review wherever you listen to your podcasts! Check out the Ready for Takeoff podcast at Wix.com/readyfortakeoff. Check out Zapier.com/HCI to explore their business automations! Go to Swag.com/HCI and use promo code HCI10. Check out the HCI Academy: Courses, Micro-Credentials, and Certificates to Upskill and Reskill for the Future of Work! Check out the LinkedIn Alchemizing Human Capital Newsletter. Check out Dr. Westover's book, The Future Leader. Check out Dr. Westover's book, 'Bluer than Indigo' Leadership. Check out Dr. Westover's book, The Alchemy of Truly Remarkable Leadership. Check out the latest issue of the Human Capital Leadership magazine. Ranked #5 Workplace Podcast Ranked #6 Performance Management Podcast Ranked #7 HR Podcast Ranked #12 Talent Management Podcast Ranked in the Top 20 Personal Development and Self-Improvement Podcasts  Ranked in the Top 30 Leadership Podcasts Each HCI Podcast episode (Program, ID No. 592296) has been approved for 0.50 HR (General) recertification credit hours toward aPHR™, aPHRi™, PHR®, PHRca®, SPHR®, GPHR®, PHRi™ and SPHRi™ recertification through HR Certification Institute® (HRCI®). Learn more about your ad choices. Visit megaphone.fm/adchoices

Josh Makower, MD, is the Boston Scientific Applied Bioengineering Professor of Medicine and of Bioengineering at the Stanford University Schools of Medicine and Engineering, and is the director and co-founder of the Stanford Byers Center for Biodesign. In this conversation with Stanford adjunct lecturer Ravi Belani, Makower unpacks the center's biodesign process and encourages entrepreneurs to find opportunities in the world of health technology innovation.--------------------Stanford eCorner content is produced by the Stanford Technology Ventures Program. At STVP, we empower aspiring entrepreneurs to become global citizens who create and scale responsible innovations.CONNECT WITH USTwitter: https://twitter.com/ECorner LinkedIn: https://www.linkedin.com/company/stanfordtechnologyventuresprogram/ Facebook: https://www.facebook.com/StanfordTechnologyVenturesProgram/ YouTube: https://www.youtube.com/user/ecorner LEARN MOREeCorner Website: https://ecorner.stanford.edu/STVP Website: https://stvp.stanford.edu/Support our mission of providing students and educators around the world with free access to Stanford University's network of entrepreneurial thought leaders: https://ecorner.stanford.edu/give.

There is a massive potential in innovation ready to be tapped. In this episode, we hear from Onike Williams, nurse practitioner and Director of Program Development at UCLA Biodesign, about how the program is working with professionals from the medical field, including nursing, to educate them as innovators and develop new technology. As she still is a nurse practitioner, she also speaks of how that balances and enriches her work and contributions to the Biodesign program. Onike explains what the program's health tech accelerator strives for and how the one-year fellowship develops ideas to patent and take to market. She emphasizes that there is no bad idea and encourages medical professionals, especially nurses, to be inspired by those ideas to innovate. Tune in to this episode to listen from Onike Williams about nursing innovation and her work at UCLA Biodesign! Click this link to the show notes, transcript, and resources: outcomesrocket.health

Al'ai Alvarez, MD aka LA is a national leader and educator on Wellness and Diversity, Equity, and Inclusion. He is a clinical assistant professor of Emergency Medicine and the Director of Well-Being at Stanford Emergency Medicine. He co-leads the Human Potential Team and serves as the Fellowship Director of the Stanford EM Physician Wellness, and Co-Chair of the Stanford WellMD's Physician Wellness Forum. His work focuses on humanizing physician roles as individuals and teams through the harnessing of our individual human potential in the context of high-performance teams. This includes optimizing the interdependence between Process Improvement (Quality and Clinical Operations), Recruitment (Diversity), and Well-being (Inclusion). Currently, he is one of the 2021-2022 Faculty Fellows at the Stanford Byers Center for Biodesign.  Andrew Petrosoniak MD is a trauma team leader and emergency physician at St. Michael's Hospital in Toronto, Canada. He's an assistant professor at the University of Toronto and he leads the translational simulation program at St. Michael's Hospital. His research focuses on the use of in situ simulation and design thinking to support human-centered care. He's also co-principal at Advanced Performance Healthcare Design, a firm that consults with hospitals, start ups and high stake industries using simulation to improve decision making and inform the design of systems, spaces and teams. White paper on simulation informed design. In 2004, Patrick MacLeamy drew a set of curves based on a pretty self-evident observation: an architectural project becomes more difficult to change the more developed it becomes. For this earth-shattering revelation MacLeamy named the curve after himself (although the title should probably go to Boyd Paulson who drew the curve much earlier [see Noel's comment to this post]). You have probably seen the graph before. It gets trotted out in every slide deck promoting BIM / IPD / or early-stage environmental analysis.  The key point is that architects expel their effort at a time when design changes are relatively costly. MacLeamy and his disciples advocate shifting design effort forward in the project, front loading it, in order to reduce the cost of design changes.

In this episode of Medsider Radio, we're sitting down with Holly Rockweiler, co-founder and CEO of Madorra.Holly spent the early part of her career working as a research scientist for Boston Scientific. In 2013, she took a fellowship at Stanford University's Byers Center for Biodesign, where she met her future business partner, Ryan Krone. Through the fellowship, Holly and Ryan developed Madorra, a non-hormonal medical device that treats vaginal dryness. As co-founder and CEO of Madorra, Holly's on a mission to improve women's health. In this episode of Medsider, Holly discusses the importance of listening to your patients when developing medtech solutions, and why having a cause can be a valuable motivator. She also shares her most valuable learnings from participating in Stanford's Biodesign program.  Before we jump into the conversation, I wanted to mention a few things:If you're into learning from proven medtech and healthtech leaders, and want to know when new content and interviews go live, head over to Medsider.com and sign up for our free newsletter. You'll get access to gated articles, and lots of other interesting healthcare content.Second, if you want even more inside info from proven experts, think about a Medsider premium membership. We talk to experienced healthcare leaders about the nuts and bolts of running a business and bringing products to market. This is your place for valuable knowledge on specific topics like seed funding, prototyping, insurance reimbursement, and positioning a medtech startup for an exit.In addition to the entire back catalog of Medsider interviews over the past decade, Premium members get exclusive Ask Me Anything interviews and masterclasses with some of the world's most successful medtech founders and executives. If you're interested, go to medsider.com/subscribe to learn more.Lastly, here's the link to the full interview with Holly if you'd rather read it instead.

Ever had a great idea and wondered if it could turn into a business? Alternatively, ever thought, I want to start my own company, but I'm not sure what I want to do? They say that there are two kinds of entrepreneurs: Those that come up with their own ideas and those that have ideas come to them. Join Isabella Schmitt as she discusses how to discipline your ideation process from several Biodesign fellows. Featuring: Jeff Sharman, MD (Medical Director, US Oncology), Nancy T. Chang, PhD (CEO, Ansun Biopharma), Heather Underwood, PhD (CEO, EvoEndo), Sinead Miller, PhD (CEO, PathEx), Tim Jones & Michelle Tierney, PhD (Founders, Symphisis Medical), Eyal Aronoff (Co-Founder, Quest Software) Sponsored by Proxima CRO

Health design thinking uses play and experimentation rather than a rigid methodology. It draws on interviews, observations, diagrams, storytelling, physical models, and role playing; design teams focus not on technology but on problems faced by patients and clinicians.  Healthcare UX, then, is about the experiences people have with healthcare technology and services. A Healthcare UX designer's job is to optimise the usability, accessibility and pleasure of healthcare technology and services. Remember, the experiences cannot be guaranteed, but they can be influenced. Clinical UX, a niche within Healthcare UX focused on the experiences clinicians and their patients have with healthcare technology and services. Dr. Delphine Huang is a medical director at IDEO Health. She works closely with design teams to bring impactful and innovative ideas to life. Her projects span from health products, services, systems and strategy design. She is also a practicing emergency medicine physician and loves hiking the California coast, finding the perfect avocado, and continuously learning from her kids. Dr Gyles Morrison is a Clinical UX Strategist with a 10 year history in healthcare. Starting as a doctor in the UK, he now works internationally, helping UX professionals and healthcare companies make products and services that are valued by clinicians and patients. His areas of interest are digital therapeutics, healthcare behaviour change, UX maturity and professional development.              https://drgylesmorrison.medium.com/what-is-healthcare-ux-and-why-is-it-so-important-be21b415e681 Health design solutions to improve the care of sickle cell patients with vaso-occlusive crisis in the emergency department https://www.youtube.com/watch?v=Am5jIA7xKJU https://drgylesmorrison.medium.com/how-to-learn-clinical-ux-through-mixed-learning-fbf147a42875 Transcript SUMMARY KEYWORDSdesign, people, Gyles, clinician, healthcare, IDEO, health, ux, moments, patients, thinking, resistance, therapeutics, clinical, digital, working, Delphine, opportunities, shared, projects SPEAKERSResa Lewiss, Delphine Huang, Gyles Morrison Resa Lewiss  01:12Hi, audience. Thanks so much for joining me. And we're talking about a favorite topic, health design and user experience by two guests or subject matter experts in after balancing a few calendars, a few continents and a few time zones. Here we are. Dr. Delphine Huang is a medical director at IDEO health. She works closely with design teams to bring impactful and innovative ideas to life. She's a practicing emergency physician at San Francisco General in San Francisco, and her projects span from health products, services, systems and strategy design. Dr. Gyles Morrison is a clinical UX strategist. He has a 10 year history in healthcare, and he started as a physician in the UK, yes, the United Kingdom. He now works internationally helping UX professionals and healthcare companies make products and services that are evaluated by clinicians and patients. So each of these physician health designers have websites and have lots of projects. I first met Delphine, when I was reading about design and Health Design, and the work of IDEO. They have some really interesting products, looking at diabetes, looking at breast pumps, looking at artificial intelligence, I first came across Gyles, when we were working on a piece together, he ultimately published this in the European Journal of Emergency Medicine in 2021. He talked about an app for the treatment, the Health Design, and patient centered treatment of sickle cell patients in the emergency department. So before the episode get started, we actually were talking a bit about design. And each of them were sharing when they first realized they were thinking like a design or how they implement design in their daily lives. And in both of their cases, they talked about taking care of patients in their clinical environments. Delfina actually added that she realizes in having two young children, she actually is designing on a daily basis. Okay, let's get to the conversation. What strikes me from what both of you have shared is because I know from working in healthcare is there's a lot of resistance. There's a lot embedded in tradition. Too many times we hear well, this is the way we've always done things. So I am sure that you are used to not just the resistance of human nature and people, but specifically the resistances within healthcare. So I'm wondering if you can share for audience members that really trying to wrap their head around this concept of design, where perhaps there's been a resistance, maybe from a patient, maybe from the healthcare team, maybe from the institution, maybe from the built environment, and how you worked through that resistance. Delphine? Delphine Huang  04:03Yeah, I mean, I think, you know, like whoever you're working with, whether it's a client or a patient, at the end of the gate, the two are also human. Right. So I think there is a, you know, when we talk about design, we talk about being empathetic, putting ourselves into their shoes. And so when you hit these moments of resistance, it's actually taking a time to slow down and actually understand, like, what is driving that? That thought process for that individual. And so, you know, a lot of love and work, I would say in design, there is the actual thing that you're trying to build or design for app or medical device, but it's also about aligning your lining, what could be multiple stakeholders also that are involved in this and so, you know, I think when you have this moment where it feels more I would maybe she A different resistance to feeling, maybe a moment of tension is to actually take a moment to be like, Okay, how can we better understand this moment tension, because within that, you might actually find the path of clarity that you need in order to then move something forward to design something forward. So an example of this would be like, you know, when we're talking to hospital administration, a lot of them are indoctrinated, or come from the theory of like, you know, LEAN improvements, or Sigma Six. And there are a lot of parallels actually, with that with design, I actually think they actually complement each other really well. And so it's about thinking about like, actually, how do you then speak their language? How do you bring in moments that there they are accustomed to and integrating that in order to be like, well, actually, and how do we elevate them through those means the principles of design, great, Resa Lewiss  05:56Gyles, what came to mind? Gyles Morrison  05:58So this is really advice, I would offer not just in healthcare as a way to overcome that resistance. But anytime you're facing resistance from people, I'm not a parent yet, but I've been around a lot of young children, or someone who, for whatever reason is against you. And I think it's that whole advice, the general advice that you would get from David Carnegie's How to Win Friends and Influence People comes to mind. And the first big take home for that is to genuinely be interested in other people, which is something we can take for granted when we're talking about friends and family. But when you genuinely care about someone else's interests, it means that you start trying to read between the lines, and whenever there's doubt to ask explicitly, but over time, because you've built a relationship with that person, you instinctively start doing what's right for them, like my wife doesn't have to ask for peppermint tea in the morning, I just notice what she's gonna want, not just from tradition, but I can sense this is probably what she's gonna want right about now. And I think this can be applied very quickly, even when you are dealing with a stranger. Just having that first genuine interest in seeing how you can help that person, which then should motivate you should guide you to be asking the right questions and observing as well, because especially in design, a lot of what we determine the requirements or satisfy a user's needs, doesn't come from what the user tells us, it can often come from what the user shows us, or better still, what we learn from what the user isn't doing or what they can't do. So it's having that inquiring mind, which still first comes from genuine care about this person's interests. So I found that always worked really, really well in healthcare, I think as well, as a doctor dealing with clinical UX and design and is genuine working in digital health. Being a clinician myself is kind of like a superpower, you kind of get a power up, where when you are speaking to fellow clinicians, and you make it very clear from the outset, you're part of the solution to their problem that you're here to help. And you understand generally, even if you've never worked with them in their department, even in their country, generally, because your clinician like them, that they can trust you and that you're going to understand them because you've got a shared language, shared experiences. And so actually, the easiest conversations I've had in digital health, and clinical UX has always been with fellow doctors, more so than anybody else, followed by all other allied health care professionals, and actually is most difficult at times working with non clinicians, who have a very strong opinion about how things should be done. So again, I have to genuinely care for their interests. Is it money that's motivating them? Is it success of the project that's motivating them? And then see, how does that tie back to what I have to do in my job? What is it linked back to my agenda, and then have that common ground and make sure both of us are happy state communicating about our needs, and then that normally leads to success, it breaks down the wall that people can have, or resistance and build that bridge to connect to so that you can walk across and get stuff done? Resa Lewiss  09:28Thanks, I really like that reframe, rather than resistance perhaps consider it tension, which can be both positive and it does not necessarily have to connote negative. So in the show notes, the audience will be able to read about your respective work your project, Delphi, and I spent quite a bit of time going through your website reading about your projects. And, you know, most interestingly is your role when you're not an emergency physician at SF general is you are a medical director for IDEO some Audience members may not know about audio. And so I'm wondering if you can share a bit about the company, your role. And can you can you let us know what are you working on right now? Yeah, Delphine Huang  10:11Sure. So IDEO is a global design consultancy firm. And we are most like when most people think of IDEO, they think of, you know, products such as Oxo or Apple, I was involved in designing the first Apple mouse, for example. But over the years, besides doing physical products, we also have expanded our services and do a majority of our work in digital experience. And also think about new ventures or new opportunities. So, a lot of times organizations come to us because they have some big question that they're trying to solve. And they're looking for a creative or innovative way to be able to do that. And so, you know, IDEO is a multidisciplinary organization where we were, I think, where our strengths lie, is that we have folks that are spanning from interaction designers, to design researchers, to business designers, to someone like me, who's a clinician, to data scientist engineers, and we believe actually, the collective mind is a lot stronger than the individual mind. And so I think, with that, you know, we are a lot of times given a challenge, and from there, able to explore new avenues that perhaps haven't been thought of yet. In terms of my role, so I am one of the medical directors in our health domain. And my role primarily is to bring in the, the, the perspective of the healthcare ecosystem, and provide that lens of perhaps the different stakeholders that might be a play and the different levers that might be in play when trying to design. And so sometimes I think I think of myself a bit of like, I'm the gut check, of, you know, we can dream all these different different solutions out there. But you know, at the same time, we also have to think about the pragmatism of it, as well, as you know, what is our current state of, you know, our healthcare system. So there's a little bit of my role in terms of projects, and current, I most recently finished a project related to home care services. And I think that this was a you know, in COVID times, you know, this is an area ripe for innovation, you know, we're seeing a lot of movement, healthcare, thinking about what the outside of hospital experience could be like. And especially at home, in our current pandemic. So, you know, I think that, you know, the that this is an area that could be the has a lot of opportunities, because it's actually a lot of patients and families that need, you know, about, I think it's like 70% of patients who use home services or Medicaid beneficiaries. And we actually do see a lot of racial disparities, elder disparities when it comes to outcome and quality of care. So given the one on one nature of home care, I think there are opportunities, one of the things that we explored was, you know, I think they, the key to there a few things that we learned along the way was one, how do we like design and integrate tools, not just for the patient, but actually for the care provider? And what are those opportunities of community interacting patients, even when that provider is not with the patient? So you can build that trust and psychological safety? And second, thinking about how can we design delightful and interactive moments for patients who have a long road of recovery? And so thinking about what is that moments of being able to share progress and build positive feedback so that people are engaged in taking care of their health? So I think, you know, these are some of the projects that we work on. And this is just an example, where design I think, has a lot of can have a lot of tools that can help individuals think through how we can improve a particular situation health. Resa Lewiss  14:11Yeah, Gyles I want to get to you about your current work, but I want to first dovetail off Delphine something you shared about access, equity, health disparities, and sort of trying to raise the level of standard that everybody is getting the same care and particularly Health Design, I think is having its moment because of COVID because of and we can talk about the US and Gyles welcome your examples from the UK and Germany. You know, it basically pulled a scab off of the racial inequities, the racism throughout healthcare, in terms of patients and even in terms of health care trainees, but for you know, for the sake of argument here, we're talking about patients the despair The racial ethnic disparities and the racism. So in, as I said, health design, I think is having its moment. And I would wonder, with your role with IDEO, how have you seen that manifest? Are you just bananas, busy with many, many projects, and many, many consultations, you know, what's been coming your way because of the pandemic? Delphine Huang 15:22Yeah, I mean, I think when it comes to thinking about equity and thinking about health equity, specifically, IDEO, along with many other organizations that we're actually seeing now are grappling with, how do we how do we, as an organization, as a health care system in the US address, some of the some of the disparities that have really been they're always there, but now really exacerbated and highlighted. And during COVID, and in some ways, there's an awareness that we there, where's not even that imperative that we address these issues. And so I think that design itself really has a role to play in that kind of all the things that we've kind of talked about, of why design is a good can be helpful in these scenarios is that, you know, thinking about how we can in a moment where, you know, COVID has really highlighted these gaps in health care, it also has been an opportunity to really bring out Creative Innovations about how health care can be delivered and to whom we're really delivering it. So I think there are these moments where I think thinking about how both the merging of technology, human centered design, and healthcare come together, are at play right now. And I think we're seeing that across all organ, a lot of organizations out there and how they're approaching their work. There's a piece of organizations being wanting to be introspective about their own journey when it comes to equity at this point, Resa Lewiss  16:53Gyles, feel free to jump on that and update us on what you're working on right now. Yes, so Gyles Morrison 16:59I primarily focus on either working independently as a clinical UX strategist. So I primarily work on products in the digital therapeutic space. So any evidence base digital tool that can prevent, manage or treat disease, this can be disease anywhere in the world, on any disease, really. But what I love about that work is that you're suddenly moving the power more towards the individual patient to take more control over their health, because they're in a position to record their data most of the time and digital therapeutics and get feedback on their health in real time, within a forms them of what sort of options that they have to improve their health, or even reassure them if they had any previous concerns, which then feeds into any new treatment plans or seeing their primary care physician, so on and so forth. And what I love about this is that a lot of the issues that we face with health inequalities can be easily overcome through the more encouraged use, encouraged development and use of digital therapeutics. So you know, depending on the statistics that you look at, it can be argued that actually, people are more likely to have access to a mobile phone, then immediate healthcare services. You know, even if it's the back in the day, Nokia 9210, with the snake game that people might remember from the 90s, even those devices still can provide a very sophisticated offering to you. So the example I like to give is M-Pesa which is commonly used across Africa, particularly East Africa, which is a completely digital service to manage your money. So you can access your bank account, just through USSD, which is similar to SMS, but it's that hash, hash key and then few digit stuff that you do in your phone, which then gives you access to your ability to not only draw money as cash from an appropriate store, but for you to even send money to other people. Let's think if that instead of having financial data had medical data, you can give even homeless people the ability to own their own health data when they have a mobile phone because many homeless people, even in very deprived parts of the world have a mobile phone. And this is one of the reasons why I love working in digital therapeutics. As I said before, it can bring that shift of power more towards an individual. So anybody who needs healthcare services at some point is going to have to interact with a professional pharmacist or doctor so on and so forth. But there's many medical problems that we have or medical questions that we have, which can be easily solved on someone's own like we've seen this We've encouraged people to, you know, Google stuff, which isn't always so useful because it doesn't take into full consideration the realities of someone's lived experience and their personal health needs. But people are trying to help themselves. But we don't really have a sophisticated suite of tools and technologies to really allow people to do this properly. So that's why I like focusing on the digital therapeutics, because when we do that, right, we will be able to serve underserved people much more with language barriers. Even confidence with using technology to improve their health, we started to empower these populations. And when we satisfy their needs, everybody else who can take modern technology for granted, their needs are satisfied as well. Resa Lewiss  20:52Do you want to tell the audience briefly about your online course your clinical UX course? Yes. So Gyles Morrison 20:57the clinical UX course, he goes into his second year in January of 2022. So the course is designed to help anybody whether they are new to UX, or experienced in UX, perhaps they've done a recent bootcamp in UX design, or they've even been in UX for 10 years or more, to gain that additional skills, knowledge and experience on working in clinical UX. So how can you change your profession and go into this field, or have it as another string to your bow, so we had nine students graduate this year in 2021. And this is students all over the world, doctors, paramedic psychologists, UX professionals, new and old. And they've loved it. I'm biased, because I taught them. But the feedback has been very, very positive. And students have been able to even get jobs whilst taking the course, because the whole course is taught part time. So it's specifically designed to help people who's in full time education or full time employment, to spend a couple of hours a week on the course, if they're already in digital health or healthcare in general, they can base their coursework on what they do in the day job, or they spend a couple more hours Additionally, in the week, if they're outside of healthcare currently. But it's really to provide people with that experience, and a group of like-minded people globally, who are really passionate about making a difference in health care, food design. Resa Lewiss  22:32Great. I want to give each of you the opportunity to ask each other questions. Delphone, you want to start? Delphine Huang  22:39Sure, I would love to hear more about you teaching about clinical UX. Actually, I'm curious if you know, whether whether things are moments where you see learners or that are taking on this endeavor of clinical UX. moments for them to what are the moments where it's like an aha moment for them? Yeah, yeah. Gyles Morrison 23:08So the most common aha moment, regardless of someone being a clinician or not, is when it's revealed to them the crazy similarities between diagnosing patients and working as a designer, the whole process of there is a problem. So you investigate it. And through your investigations, you might start having ideas of what the solution could be your treatment plan. And so you give it to treatment, but then you still do a check to see you know, you know, an evaluation, further blood test, whatever the investigation that is required, and even still be saved in his life. So here's the treatment, we expect you to get better, but it'd be any problems, come back and see me the same thing you should be doing in design, someone comes with a brief, you gather as much information as possible. And you go through that cycle of understanding the problem, as well as possible, narrowing down to the right problems to solve, exploring potential solutions, testing out improving, and then making sure that if, after someone's been given a solution, they need to make any changes, they can come back to you. And so when conditions in particular, doctors realize that they're like, Wow, I get this, and I care about this. It's, it's not so hard to do is like as much as I need to learn new skills. It's that mindset change that people fit they need to go through as clinicians, we say don't they don't need to change the mindset. The only thing about the mindset that needs to change is to realize that you won't just be now using your medical degree and experiences, there's going to be some additional knowledge you're going to have to have, but otherwise you're in a good place to solve problems in healthcare as a design if you come from a clinical background. And then when the non designers I'm sorry, the designers realize this when the UX to start understanding this as well. They like I now see how Ready got such a common ground with clinicians, I can see how I can start a conversation with them and get them on my side because we've got this shared experience, even if it's seems to be different industries and different problems that's been solved. So that's perhaps the best aha moment that I see. amongst the students. The other one is when they realize how much they can earn, when they stay. That's another one that what okay, I definitely, I really like this whole clinical UX thing. Let's let's go for it, then. Yeah. Resa Lewiss  25:34Gyles, what do you want to ask? Delphine? Gyles Morrison 25:37Um, I'm really keen to know, what advice would you offer your younger self? Because I'm assuming that you weren't involved with design, before medical school? And if you didn't know about design, then would that have changed your your path in life? Delphine Huang 26:03Um, good question. Um, I don't think it would necessarily have changed the path, per se, I think that, at the heart of it, I'm still physician, and I still love the art of medicine. I think that, though, when I, you know, when I think back to folks have come to me and be like, you know, how do I get started on a journey similar to yours, I would say that, that, you know, the path at the end of the day is not clear. Because in medicine, you always have, you kind of have this trajectory that you go on, you go through medical school, and then go to residency become attending. And that path is very clear. But when I think for all of us out here on the call is that is that you have to forge your own path at the end of the day, but that you should take the opportunities as they come because you never know where it will lead you. And it's whether or not it's, you know, helping with a startup just help sit through their UX experience, and you're doing it as maybe something you do as a med student, or going to conferences and meeting different people in the industry, you start hearing some of their pain points, and what they may be struggling with, because a lot of those folks don't have experience in health care, and don't even have a weight of the lens to be able to get it. And so that can be you, right. And so I always tell folks, you know, use the opportunities as you especially as you're going through training, to one learn about the pain points of the industry, but then also learn the pain points of your hospital. Prior to coming out of prior to coming to IDEO. And prior, I had done a fellowship at Stanford called Biodesign. I had never thought about you have this physical product, let's say, let's say a ventilation machine. And then I never thought about who makes that machine? What goes into the design of it. What is components that need to be in there? What is the supply chain from being built in a manufacturer all the way with regulation, with the delivery to and training of an individual to use it, each of those steps, as someone who's early in it, who's working at the hospital had the opportunity to learn and that knowledge is so useful to somebody else in the industry? So I would say that those are the those are the things I would tell folks as they're thinking about either whether it's you know, doing something part time or making the jump fully into industry, that if you're a clinician, you can you can learn those moments and bring that knowledge to others. Resa Lewiss  28:59I know I say this every week, what a great conversation. But seriously, what a great conversation. I think it's obvious to you audience how much Delphine Gyles and I love speaking with each other and love the topic of health design and user experience. Delphine shared that this may have been one of her first podcast recordings, and I'm so glad and feel so lucky to be able to amplify her amplify her leadership as a health designer, and amplify her work. As an ideal Medical Director. Gyles and Delphine are people to watch in the health design and user experience space. You audience have a role in health design, you are designers. Think about your health. Think about health care. Think about health care that can better serve society. See you next week. The visible Voices Podcast amplifies voices both known and unknown, discussing topics of healthcare equity and current trends. If you enjoyed this episode, please rate and review us on Apple podcasts. It helps other people find the show. You can listen on whatever platform you subscribe to podcasts. Our team includes Stacy Gatlin and Dr. Giuliano deport you. If you're interested in sponsoring an episode, please contact me resa@visiblevoicespodcast.com. I'm based in Philadelphia, Pennsylvania, and I'm on Twitter @ResaELewiss. Thank you so much for listening and as always, to be continued